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1. Executive summary 
 
Introduction and methodology: 
In the United Kingdom, one in six people aged 18 or over report symptoms of a common mental disorder such as 
anxiety or depression. Despite the growing interest in the quality of care for depression, there has been little 
evaluation of this in primary care settings. Digital technology, including applications (apps) for mobile phones and 
tablets are being created to complement clinical care  and more than 13 web applications and 35 smartphone 
apps are available in the NHS for depression, anxiety or stress.  
 
This report details findings from the implementation and evaluation of a new service, seeking to optimise the 
current depression care pathway in a primary care setting. A 'walk-in' service was piloted for one year at two GP 
services (a single primary care network) using a multi-disciplinary team of health/social care professionals with 
specialist knowledge of mental health and wellbeing providing a range of therapy options. Built into the service 
was the use of a novel digital technology, i-spero, designed to assist service users with managing depression and 
supporting professionals in clinical decision making and management.  
 
The service evaluation followed a mixed methods, observational feasibility study design, using an evidence 
integration triangle implementation research approach to identify changes in context regarding implementation 
and resource use, who and what was affected and how, the effects on user outcomes and experiences, plus the 
experience of healthcare professionals. The evaluation follows the NICE evidence standards framework for digital 
health technologies. The study comprised an intervention group of service users (n=109) who received six months’ 
care for low mood, depression and/or anxiety from the new service, compared to a standard care group (n=48).  
 
Specifically, the evaluation set out to answer the following questions:  
 What impact has the systematic pathway had on service user experience and outcomes?  
 What are the components of the care delivery model (‘active/successful ingredients’) that are really 
making a difference?  
 What are the influencing contextual factors and how have they affected implementation and outcomes? 
 What changes to the use of resources and activity have occurred and how have they impacted costs? 
 What could be improved, replicated and sustained? 
 
Service user experience and outcomes of the new care pathway 
 The walk-in clinic was rated highly with 95.5% happy with the care received. Services exceeded 
expectations for 56.5% of service users in the intervention group compared to 20.5% in the standard care 
group (p<0.001). 
 Services users were happy to use the i-spero technology to guide their care and management, found it 






“100%. Yeah, I think it’s much much better than any other service I’ve had around mental health.” (SU59) 
 
“You just need to look at the scores and you can see people are improving… I think that’s actually boosting the 
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 The intervention group exhibited lower depression symptoms when compared to the standard care group 
after six months of care (p=0.47) and significant improvement in symptoms over time (p<0.001). 
 Recovery was observed in 35.4% of participants using the new service and clinically relevant improvement 
in 59.6% of participants in this intervention group.  
 No difference in anxiety symptoms nor service user wellbeing were observed between the groups. 
Borderline differences in severity of suicidal ideation between groups was observed after six months of 
care, favouring the new service. 
 





















Influencing contextual factors 
 Changes to the local commissioning landscape emphasised the need for continued commissioner 
enagagement, especially with regard to sustainability of the service. 
 Primary care is experiencing increasing demand for services which impacts on the ability to deliver 
enhanced services. 
 There is high demand regionally and nationally for mental health services. This issue of capacity limited 
the recruitment of mental health practitioners and influenced the presentation of service users who had 
greater severity of illness than expected. 




















Integration between the 
clinic, the app and service 
user involvement 
Options and choice 
available to service 
users 
Multi-disciplinarity 
Pathway champions and 
clinical leadership 





Flexibility (ability to change 







“I can safely say it is absolutely down to accessing the clinic because …. I’ve now got the tools and the access 
and the support that I think I need …” (SU45) 
 
“I would say a majority of the clients that I saw in the clinic that went on to have therapy, probably recovered at 
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 The COVID-19 pandemic led to changes in the delivery of the service and impacted on the referral rates 
into the service. 
 
Service resource use and cost 
 In line with other enhanced services, the average total costs for the use of health and care services were 
higher – £591.66 (SD £519.19) for the intervention group compared with £230.88 (SD £378.83) for 
standard care (p<0.001). 
 Running the clinic was expensive largely due to the additional services provided, overheads and staff costs, 
especially on a Saturday. The number of service users seen was sub-optimal and, as a walk-in clinic, was 
unpredictable, which made balancing staff costs difficult. The use of the technology was seen as 
expensive. 
 Costs were expected to reduce over time as a result of reduced appointment times (without the need to 
consent to take part in the evaluation) and the use of technology at scale. In the longer term, the benefits 
of people with mental health needs being seen early, by the right clinicians and with the right access to 
timely therapies, were expected to result in reduced treatment costs. 
 
What could be improved, sustained or replicated 
Findings were further organised to extract (1) what improvements were needed to optimise the pathway, (2) 
which key elements then required sustaining long-term and (3) which key elements should be replicated if a similar 
clinic was established elsewhere, despite the importance of different contexts.   
  
Improve (1) Sustain (2) Replicate (3)
1. Widening referral and 
advertising to increase clinic use 
Structured clinic based on triage 
and integration of services 
Professionals in primary care with 
a special interest/skills in mental 
health 
2. Integration into standard 
practice, e.g. admin support 
Providing options and choice in 
one place or dedicated clinic  
Taking time with service users to 
provide holistic care 
3. Reduction of waiting times Champions and effective 
leadership  
IT support for 
professionals/services users for  
i-spero and implementation 
4. Peer support provision to 
complement services 
Team reflection/communication 
with flexibility to adapt to need 
Symptom tracking was seen as 
key to service user improvement 
5. Other methods of triage outside 
technology (i-spero) – 
accessibility 
Timely access to treatment, 
avoiding waiting lists  
 
6. Adapting delivery to reduce cost 




7. Further aligning delivery to 
needs of people with severe 
depression 
  
8. Improving referral rates from 
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2. Introduction 
In the United Kingdom, one in six people aged 18 or over report symptoms of a common mental health disorder 
such as anxiety or depression1-2. The total cost of services for depression in England in 2007 was estimated to be 
£1.7 billion and projected to continue to rise in future3. Depression is a broad and heterogeneous diagnosis and 
may occur alongside other common mental health disorders such as anxiety4. Depression is typified by depressed 
mood and/or loss of pleasure in most activities and the severity is determined by both the number and severity 
of symptoms, as well as the degree of functional impairment4. Depression is treated with lifestyle interventions, 
psychological therapy and/or antidepressants; however, the success rate of treatments varies with most exhibiting 
modest success rates of around 50% for recovery1, 5.  
 
Depressive disorders are most often managed by a general practitioner (GP) in primary care, unless the severity 
of depression is such that care is required from a specialist6. Many service users seek help from their GP or local 
National Health Service (NHS) Improving Access to Psychological Therapies (IAPT) service but commonly have to 
wait some time for assessment and treatment1. Moreover, the assessment and treatment provided by GP 
practices in accordance with National Institute for Health and Care Excellence (NICE) guidelines varies widely 
across the country and the quality of care critically depends on the individual GP’s interpretation of guidelines and 
their own knowledge of mental health conditions4. Poor levels of detection, treatment and monitoring of 
depression have been highlighted in primary care settings7 leading to service users with depression exhibiting 
reduced health-related quality of life8. Despite the growing interest in the quality of care for depression, there has 
been little evaluation of this in primary care settings7-9.  
 
Digital technology, including applications (apps) for mobile phones and tablets are being created to complement 
clinical care for common mental health conditions. More than 13 web applications and 35 smartphone apps are 
available in the NHS for depression, anxiety or stress10. There is also large diversity in how these apps work and 
what they provide to users; many act as, or feature, mood trackers which allow the user to plot their moods and 
general wellbeing on to a graph or scale10. Given the pace of change in these digital technologies, research to 
understand the quality and effectiveness of these apps is often missing, with no general requirement for 
technology providers to demonstrate beneficial outcomes through clinical trials or other means11. However, in 
those with depressive conditions, smartphone apps have been shown to reduce symptoms with moderate positive 
effects12. More research is required to understand how these technologies can support care provision which 
should be focused on understanding reach, adherence, barriers and cost11. Furthermore, to have a public health 
impact, research on implementation in a ‘real world’ setting and application to prevention is required11. 
 
A 'walk-in' service was piloted for one year at GP services in Faversham, Kent to provide access to a multi-
disciplinary team of health/social care professionals with specialist knowledge of mental health and wellbeing and 
a range of therapy options. Built into the service was the use of a novel digital technology, i-spero, designed to 
assist service users with managing their depression and to support healthcare professionals in clinical decision 
making and management. This evaluation of the new service aimed to identify changes in context regarding 
implementation and resource use, who and what was affected and how, the effects on user outcomes and 
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3. Methods 
3.1. Overview of the intervention 
With the support of NHS Canterbury and Coastal CCG (CCCCG) and funding from Innovate UK, a new care pathway 
was implemented as part of a local service re-design within a primary care setting across two GP services in 
Faversham, Kent. The aim was to provide a new integrated service pathway for those with low mood, anxiety and 
depression through a walk-in clinic setting utilising multi-disciplinary staff.  The service comprised GP triage 
followed by multi-specialty care provision for treatment including access to anti-depressant therapy through GP 
prescribing, psychological therapy and wellbeing support at a single point of access. Assessment for psychological 
and talking therapies was provided within the clinic in partnership with a local Improving Access to Psychological 
Therapies (IAPT) provider to offer NICE recommended therapies, such as cognitive behavioural therapy (CBT), for 
common problems involving stress, anxiety and depression through healthcare professional or self-referral. 
Support for lifestyle and behaviour changes was provided by health trainers from the local OneYou services; a 
Public Health England supported initiative delivered by the NHS to provide services aimed at supporting people to 
stay fit, healthy and well. All service users were requested to use the i-spero digital technology (P1vital Ltd) in 
order to complete symptom assessments for triage and management of care. Appendix 1 provides a flow diagram 
illustrating the initial pathway designs implemented on 9th July 2019. As part of the service evaluation design 
(section 3.2), changes to the intervention pathway were allowed in order to maximise implementation during the 
pilot period. Changes made during the pilot year of the service are summarised in Appendix 2. 
 
The i-spero digital technology is a web application that can be accessed online using a phone, tablet or computer. 
It is designed to be used by both service users and health/social care professionals to assist with triage, symptom 
assessment, treatment response, follow up and care planning for service user self-management. Service users 
were asked to use i-spero to assess and monitor their symptoms of low mood, depression and anxiety using 
validated assessments: Patient Health Questionnaire 9 (PHQ-9)13, Generalised Anxiety Disorder Assessment 7 
(GAD-7)14 and the PReDicT test (Predicting Response to Depression Treatment)15,16 for assessing antidepressant 
treatment response. The i-spero technology also uses the results of these assessments and care planning 
management to inform health/social care professionals’ care provision, remote follow up and to identify service 
users ‘at risk’ through alerts for symptom deterioration and suicidality. 
 
3.2. Service evaluation design 
This service evaluation was delivered by the Centre for Health Services Studies at the University of Kent and was 
conducted independently of the delivery and implementation of the intervention. The evaluation took place 
between July 2019 and August 2020 with participants recruited over a seven month period (July 2019 to January 
2020) followed by six months of follow up from February 2020. The evaluation followed a mixed methods, 
observational feasibility study design, using an evidence integration triangle implementation research approach 
to identify changes in context regarding implementation and resource use, who and what was affected and how, 
the effects on user outcomes and experiences, plus the experience of healthcare professionals17. The information 
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a difference17. The evaluation was designed in line with the NICE evidence standards framework for digital health 
technologies18. 
 
Specifically, the evaluation set out to answer the following questions:  
 What impact has the systematic pathway had on service user experience and outcomes?  
 What are the components of the care delivery model (‘active/successful ingredients’) that are really 
making a difference?  
 What are the influencing contextual factors and how have they affected implementation and outcomes? 
 What changes to the use of resources and activity have occurred and how have they impacted costs? 
 What could be improved, replicated and sustained? 
 
The evaluation was conducted alongside the roll out of the new service for low mood, anxiety and depression 
hosted at a single primary care GP practice in Faversham, Kent but offered referral and access to patients across 
two practices in the area and within a single primary care network (PCN).  Participants involved in the evaluation 
were initially recruited across both practices, however, participants from the non-hosting practice had to be 
excluded from the evaluation analysis due to the inability to access data for use in the evaluation from participant 
medical records at this practice. Appendix 3 presents a flow chart of the evaluation and illustrates the sample 
groups and data collected. Data were collected from two sample groups as described below. 
 
3.2.1. Intervention Group 
An intervention group comprising prospective service users who had received six months of care for low mood, 
depression and/or anxiety from the new service (target sample n=100) who were over 18 years of age and had 
agreed to use i-spero to support their care. Those considered to require emergency assessment by a GP with a 
view to referral to secondary care were excluded unless they were subsequently deemed eligible for GP-based 
care. All service users attending the new service and fitting the eligibility criteria above were invited to take part 
in the service evaluation between 6th July 2019 and 1st February 2020.  
 
3.3.2.        Standard Care Group 
A standard care group comprising service users identified in the GP practice records as having low mood, 
depression and/or anxiety (service users who had a code for low mood, depression and/or anxiety and/or who 
had been prescribed an antidepressant) prior to the introduction of the new service and who had not attended 
the new service (target sample n=100), were over 18 years of age and able to provide consent online. All eligible 
service users between 1st July 2018 and 30th June 2019 were identified from the GP practice records and were sent 
an email containing an information sheet and details of how to take part in an online survey on one occasion only. 
A second email and a single text message were sent to non-responders of the initial email. 
 
3.3. Ethical considerations 
The project was sponsored by the University of Kent (Reference: ResGov 414) and given a favourable opinion by 
the School for Social Policy, Sociology and Social Research SRC ethics committee (Reference: SRCEA id 232). All 
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willing to take part, written consent was then received by the consulting health/social care professional for the 
intervention group and online consent was provided for the standard care group. If service users using the new 
service did not want to take part at the first visit, they were given the option to change their mind at any time and, 
if so, to contact the research team.  Participants were free to withdraw from the evaluation at any time and this 
was made clear in the information sheet and consenting process, including the fact that data collected up to the 
point of withdrawal would be used according to the original consent unless they specified otherwise. Participants 
were also made aware that taking part would not affect the care they received in the service. 
 
As this was an observational evaluation, the risks to service users was low. The evaluation and data collection was 
designed to create minimal burden on participants and where significant time was needed to provide data e.g. 
interviews, these elements were optional. Suicidal thoughts are common in service users with depression. Such 
thoughts obviously indicate a risk of suicide, although this risk is itself relatively small. i-spero measures suicidal 
thoughts within the PHQ-9 questionnaire and, if indicated, the healthcare team were notified automatically by i-
spero. If a research team member was concerned about the health or wellbeing of a participant when in contact 
with them or from symptom data received from the control group, the participant’s GP was contacted with the 
participant’s consent and following the evaluation duty of care protocol. 
 
3.4. Public involvement in the project 
In partnership with Maidstone and MidKent Mind (project partner), a public involvement group was established 
to advise the evaluation throughout. Five members were recruited from Mind support groups who had lived 
experience of low mood, anxiety or depression, interested members of ‘Opening Doors to Research’ patient and 
public involvement group (Centre for Health Services Studies, University of Kent), or from local GP practice patient 
participation groups. The public involvement group was involved in assessing and recommending improvements 
to the i-spero prototype, design of the evaluation, participant information sheets and documents, reviewing clinic 
advertising and results during the evaluation, and reports and public dissemination activities.  Appendix 4 provides 
a summary of input and changes made as a result.  
 
3.5. Data collection 
A mixed methods approach was used to collect data for analysis.  
3.5.1. Quantitative data 
Outcome, experience and economic data for the intervention group were collected using the i-spero web 
application at baseline, 4-8 weeks and six months of received care. Standard care group data were collected using 
a single timepoint online survey for participants who had received at least six months of care. All other data was 
collected from participants’ medical records with consent for both groups (included demographics, past medical 
history, medication and primary care service use). Participant-reported symptom and wellbeing outcomes were 
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time point, intervention group participants also completed a service experience questionnaire designed for the 
study with closed questions. 
 
To understand representativeness of the sample populations, anonymised data were also collected from the i-
spero application and the GP practice which included demographic data (sex, age, co-morbidities and anti-
depressant medications) for all services users coded with an appointment for depression during the evaluation 
recruitment period plus mean, minimum and maximum PHQ-9 and GAD7 score for all services users using the new 
service during the evaluation recruitment period. 
 
3.5.2. Qualitative data  
Qualitative data were collected from intervention group participants only.  At consent, participants were invited 
to share contact details to take part in two optional semi-structured telephone interviews (n=15-25) at 4-8 weeks 
and around the six-month follow-up time points to explore their experiences of receiving the service, the technology 
involved and to identify the facilitators and barriers to sustaining the service. Aspects relating to changes in their 
health, and service use behaviour were also explored. In addition, qualitative focus groups (n=6-8 people each) and 
interviews were undertaken with the new service implementation staff at 6-8 weeks after the start of the new 
service and again at 9-12 months. These data explored the experience and nature of the new service provision to 
identify any challenges, ‘active ingredients’ and changes during development and roll out of the new service, 
successes, transferability and sustainability. Findings from early focus groups (6-8 weeks post intervention start 
date) were fed back to the project steering committee and the health/social care provider team to enable rapid 
feedback into practice of what was working and what was not, so changes could be made and observed in real 
time. Telephone interviews were also conducted with 5-10 wider key informants  (e.g. other GP practice staff 
involved, other health/social care professionals, technology/other providers and healthcare commissioners in the 
Kent region) at month 11-12 in order to gain a wider perspective of the potential impact of the intervention. Field 
notes were written up by researchers during qualitative fieldwork to capture the context and environment at the 
site as the intervention was being rolling out. Notes included detailed summaries of activities, events and 
behaviours and the researcher’s initial reflections on them22.  
 
3.6. Sample size and data analysis 
3.6.1. Sample size 
The evaluation aimed to achieve 100 service users taking part in each sample group. All participants in the 
intervention group were followed up for six months.  An attrition rate of 20% at six months was estimated, leaving 
the sample for analysis as a minimum of 80 participants. The aim of data analysis was to analyse both quantitative 
and qualitative data individually according to the specifications outlined below, and then to blend the data through 
data triangulation to address the research questions (see 3.2).  
 
For the standard care group, all service users presenting to the GP practice hosting the new service, who met the 
inclusion/exclusion criteria, were invited to take part in the evaluation. Data from a single practice in Faversham 
with a population of 18,000 patients, suggested an estimate of 17 service users attending each week for low mood, 
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approximately 800 service users were anticipated to have received an episode of care for low mood, depression 
and/or anxiety (and/or prescribed an antidepressant as per the control group definition) at least six months prior 
to the implementation of the new service. With an estimated 10% uptake, the target sample size for the standard 
care group was a minimum of 80 service users. 
 
In this study context, the usefulness of an a priori power calculation would be limited. Given the feasibility nature 
of the study, we did not have the necessary parameters to assess the effect size of the expected difference 
between experimental conditions. However, it was possible and more meaningful to perform a sensitivity power 
analysis. This revealed that with the expected and adjusted sample size of n=80 in each condition, a one-tailed 
hypothesis with alpha=0.05 for a between subjects t-test, we would have enough power at beta=0.80 to detect a 
medium to small effect size of d=0.3923. 
 
3.6.2. Quantitative data analysis 
Participants were excluded from the quantitative analysis of outcomes and economic analysis in the intervention 
group if they were registered at the GP practice in Faversham but not participating in the evaluation (intervention 
group, n=18), did not consent to use of their medical records (n=3), did not have any i-spero data (n=3), 
deregistered from Newton Place Surgery before the end of the study (n=2) or did not complete follow-up visits 
within window (intervention group, n=3). Exclusions from the standard care group were for participants who did 
not provide full online consent (n=6, all not consenting to use of their medical records), they had used the new 
service (n=2) or incomplete data were obtained in the survey (n=6).  
 
Quantitative data were analysed using SPSS (v11) and Stata SE (v15.1) software. Descriptive statistics were used 
to analyse all quantitative data and compared where available between standard care and intervention groups 
using appropriate statistical tests, which included parametric as well as their non-parametric equivalents 
(Wilcoxon Mann-Whitney test, independent sample t-test or Chi-squared test). The aim was to establish any 
significant differences between the groups at the six-month time point and within the intervention group only to 
look at changes over time at the 4-8 week and six-month time points. 
 
3.6.3. Qualitative data analysis 
Interview, focus group and field note data were transcribed and analysed using the content analysis software 
NVivo (v10). Data were subject to content analysis using Flick’s (1998) approach24. In short, a predetermined 
coding framework was used to categorise data designed in line with data collection question guides. Transcribed 
data and quotes were sorted into the predetermined categories and coded according to the origin of the quotes. 
Each category was then analysed into themes using the quotes to justify interpretation. Data that did not easily 
fit into the predetermined categories was set aside and separately thematically analysed. To ensure a credible and 
unbiased analysis, a second researcher checked the analysis trail. 
 
3.7. Health economics analysis 
The health economics analysis aimed to assess changes to resource use and activity that occurred as a result of 
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social care provider (NHS). Additional costs incurred by the service user, including out-of-pocket expenses and loss 
of earnings were limited and considered in an additional analysis to capture the societal perspective. The aim of 
the main analysis was not to perform a full economic evaluation whereby the cost-effectiveness of the new service 
would be assessed compared with standard care. Nevertheless, and cautious of the small sample size for the 
control group, we attempted to estimate an incremental cost-effectiveness ratio (ICER), which could inform a 
larger study with an economic evaluation element in the future. In order to calculate the ICER, we further had to 
consider a measure of effectiveness, expressed as quality adjusted life years (QALYs) in line with the NICE 
reference case28.  
 
In addition to the above exclusions for outcome data, some participants in the intervention group did not have 
baseline health-related Quality of Life data (QoL, n=9). It is not common practice to impute missing QoL data at 
baseline, hence these were excluded from the health economics analysis sample. Further, some participants did 
not complete their follow-up assessment at 4-8 weeks (10%) and six months (38%) despite the text reminders 
sent. For these cases, missing QoL and health and social care costs were imputed using multiple imputations via 
chained equations25-26. We assumed missingness at random at each time point in order to use as much as possible 
of the available information for each variable. As a rule of thumb the number of imputations should equal or 
exceed the fraction of missing information27, therefore, we ran a multiple imputation analysis with 40 imputations 
generated. To ensure best fit of the imputed results, imputations were based on the following predictor variables: 
sex, age, number of comorbidities, family depression history, prior prescription of anti-depressants, QoL score at 
baseline and PHQ-9 total score at baseline. The base case sample (i.e. after imputation in the intervention group) 
was 111 service users (40 in the control group and 71 in the intervention group); this is the sample used in the 
health economics analysis. 
 
3.7.1. Resource use data  
Resource use data specific to running the Saturday clinics provided by the GP practice were considered separately 
as part of costing the new service (see Appendix 5.1). To ensure accurate and pragmatic costing of the Saturday 
clinic for the intervention group, a micro-costing approach was used whereby an intervention cost was calculated 
for each participant, accounting for the number of times they attended a Saturday clinic as well as the type and 
duration of appointments they had during these visits. Additional costs considered in these calculations were the 
time of reception and management staff (including admin and overtime), which was proportionate to the total 
number of service users attending the clinic each week. Finally, any i-spero hosting and helpdesk costs incurred 
by the app developers (£465 per month between July 2019 and June 2020; £230 per month between July 2019 
and February 2020) were split across the participants in the intervention group, accounting for the total number 
of users attending the clinic per week. 
 
The remaining resource use data were collected at six months from the participants (via i-spero in the intervention 
group; online survey in the standard care group) and GP practice records. We broadly divided resource use into 
the following categories: primary care services, health trainer wellbeing service (OneYou), Improving Access to 
Psychological Therapies (IAPT) service, community-based services and hospital inpatient and outpatient services. 
Resource usage was converted into costs using unit cost figures from the Personal Social Services Research Unit 
(PSSRU)29, the Department of Health and Social Care National Schedule of NHS costs30, and information from local 
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Unit costs for any prescribed anti-depressant medication were obtained from the electronic market information 
tool31. Medication details including the dosage, date started and date stopped were entered into the practice 
electronic system and extracted by the practice research staff on behalf of the evaluation team for a period of six 
months. The number of days on which the medication was taken was calculated using the aforementioned dates. 
All the unit costs and dosage details for the anti-depressant medication prescribed to the study groups are shown 
in Appendix 5.3. These unit costs together with the package and dosage details as well as the number of days the 
medication was taken were combined to calculate the cost of anti-depressant medication for each service user. 
Differences in costs across time points and between groups were evaluated using Mann-Whitney U-tests. The 




QALYs represent a quality-of-life-weighted survival value in which 1 QALY is equivalent to 1 year of full health. 
Participants’ health-related quality of life (QoL) was assessed using the EQ-5D-5L instrument32-34 at baseline, 4-8 
weeks and six months for the intervention group, and at six months for the standard care group. Since there was 
no indication of the QoL for the standard care group (required for the calculation of QALYs) at baseline, we strictly 
assumed that they had the same QoL as similar respondents in the intervention group (i.e. we matched 
respondents based on age and sex at baseline). In line with recent NICE guidance, and in the absence of an 
acceptable valuation set for the EQ-5D-5L, individual responses to the instrument were converted into health-
related QoL scores using a validated mapping function tool35-36. Changes in QoL scores across time points and 
between groups were evaluated using two-sample t-tests. Health-related QoL scores were multiplied by the 
proportion of 1 year the time period represented (for example, baseline to six months=0.5) to calculate QALYs. 
Average QALYs between adjacent time points were calculated to generate smooth estimates between time points 




                                  +{[(QoL_midpoint+QoL_6months)/2]×b} 
 
where ‘midpoint’ refers to the first follow-up assessment; a and b are the proportions of one year the first follow-
up represented which vary by participant in the intervention group as they completed the assessment between 










Newton Place Surgery is a medium size practice with a list size of 15,348 patients (2019-2020 data37). It is one of 
two practices in Faversham which make up a Primary Care Network (PCN).  Quality and Outcomes Framework 
(QOF) data37 indicate an incidence of depression in 2019-2020 of 16.5% of the practice list (n=2537) which is 
slightly higher than the national average of 11.6%. The total urban population of Faversham is 20,110, of whom 
48.1% are male and 97.7% are white (2019 mid-year population estimates, Kent County Council38).  Just under 
one-fifth (18.4%) of the population are aged 64 years or older, with 18.9% of the population living with a long-
term health condition that limits day to day activity and 5.5% reporting to be in bad or very bad health38. 
 
4.1. Intervention use  
4.1.1. Walk-in clinic use 
The start of the new service began on 9th July 2019.  In the first year of operation (9th July 2019 until 25th July 2020), 
a total of 605 people (232 new service users, 374 follow up appointments) used the new service (Figure 1). The 
average number of service users attending was 11 per week (mean = 10.8, min-max 3- 26 in any one week), 
comprising an average of four new appointments (mean = 4.1, min-max 0-12 in any one week)  and seven follow 
up appointments (mean = 6.7, min-max 0-26 in any one week). 
 
Figure 1: New service footfall during the first year of operation. 
 
Figure 1 shows the weekly number of people attending the new walk-in clinic service for low mood, anxiety and depression.  
The y-axis indicates cumulative number of service users each week (solid line), number of weekly new services users 
attending (dotted line) and number of follow up appointments (dashed line) with key data points indicated on the graph. 
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4.1.2. Use of other services within the intervention – IAPT and OneYou services 
During the study recruitment period (July 2019-February 2020), 102 service users were seen by IAPT on a Saturday 
morning as part of the pilot. Of these, 70 (88%) were taken on for a course of treatment, with five appointments 
per service user on average. A total of 170 appointments were delivered on weekdays, with the most common 
treatment being Step 3 Counsellinga, and the least common Step 2 Counsellinga. In the same period, 86 service 
users were seen by OneYou on a Saturday morning, and of these, 29 (34%) accepted the full service. Fewer 
appointments (n=67) were delivered outside of the walk-in clinic on a Monday or a Friday where appointments 
were arranged after clinic attendance. The most common goal themes set by the service users included for 
example, reducing stress/anxiety, increasing exercise and reducing alcohol/drug consumption (for more details, 
see Table 1).  
 
Table 1: OneYou common goal themes set by the service users 
Wellbeing Healthy eating Alcohol and/or drug use 
 signposting to 
community assets 
 increase fruit and 
vegetables 
 reduce alcohol 
consumption 
 reduce stress/anxiety  complete a food diary  reduce drug use 
 connect with others  eat regular meals  
 take up a hobby  plan meals and write 
shopping list 
 
 medication and 
breathing exercises 
 increase light exercise  
 learn something new  increase moderate exercise  
 volunteering  contact exercise support 
programme 
 
Source: North and West Kent OneYou 
 
4.2. Evaluation sample groups 
4.2.1. Sample group recruitment 
All those attending the new service were invited to take part in the evaluation as part of an intervention sample 
group.  Recruitment occurred between the start of the new service on 6th July 2019 and 1st February 2020 with a 
total of 109 participants recruited within this period (exceeding the recruitment target of n=100). An average of 
3.5 service users (min-max 0-9) were recruited each week, with 38.5% of those invited going on to consent to the 
evaluation. Figure 2 below summarises recruitment to the intervention group over time. No participants withdrew 
consent for the evaluation during the study. The final intervention group sample was n=80 after exclusion of 
participants (see Methods for exclusions). The percentage of participants who did not complete follow up data 
was 17.5% (n=14) at the 4-8 week visit and 41.3% (n=33) at the six-month follow up visit assessed by completion 
of both PHQ-9 and GAD7 symptom questions at these timepoints. 
                                                          
 
 
a NHS Stepped Care Model for depression services includes: Step 1 for recognition of symptoms is assessment, Step 2 for mild depression is watchful 
waiting with guided self-help, computerised cognitive behavioural therapy, brief psychological interventions and wellbeing support, Step 3 for moderate or 
severe depression is medication, psychological interventional and social support, Step 4 and 5 is for recurrent or treatment resistant depression and risk to 
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Qualitative data were collected through individual interviews with participants receiving the intervention and a 
mixture of focus groups and individual interviews with health professionals and wider key informant stakeholders. 
Of the 72 participants who consented to being contacted about taking part in qualitative interviews, 35 took part 
in an interview 6-8 weeks after their first visit to the clinic, exceeding the 15-25 interview target. Of these 35, 20 
also took part in a short follow-up interview six months after the initial visit to the clinic. All interviews were carried 
out over the phone.   
  
Two in-person staff focus groups were held 6-8 weeks after the start of the clinic. Seven staff took part in the 
operational staff focus group, and three were present at the managerial staff focus group. These were followed 
by five individual telephone interviews with focus group participants (one representative from each distinct 
profession/role took part). Due to the restrictions imposed by the COVID-19 pandemic, staff focus groups could 
not be held 9-12 months after the commencement of the clinic. Instead, seven individual telephone interviews 
were held, three with managerial and four with operational clinic staff.  Recruitment exceeded the original target 
for this group.  
  
A further six telephone interviews were held with eight wider stakeholders; four of these were individual 
interviews, while the remaining interviews had two participants in each. Wider informants included staff at the 
GP surgery referring to the clinic, but not involved in clinic delivery, technology providers and IAPT, as well as One 
You service managers whose staff were part of the clinic.  Recruitment met the original target for this group. 
 
Figure 2: Recruitment to the intervention group. 
 
Figure 2 - cumulative recruitment of service users (y-axis) over time to the intervention group (dotted line).  This is 
compared to cumulative clinic attendance (solid line) which includes new and follow up service users.  Predicted 
recruitment prior to study start is shown with a dashed line. Weekly clinic data is represented, however, only the first 
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For a standard practice comparison sample, practice records were used to identify service users who had not used 
the new service but had received at least six months of standard care for low mood, depression and/or anxiety 
between 1st July 2018 and 30th June 2019. A total of 414 eligible service users were identified and invited to take 
part between 23rd September 2019 and 30th April 2020, of whom 48 consented to take part in the evaluation via 
online questionnaire (12.0% response rate, exceeding estimated response rate of 10%).  Accounting for those who 
had used the new service and those who did not complete the full questionnaire or provide full consent, 40 service 
users provided complete data for use in the standard care group. Fifteen of the 48 consenting participants (31.3%) 
in this group provided data that warranted reporting to their GP to ensure patient safety.  This was due to 
indications from symptom questionnaires that they continued to have severe symptoms of depression and/or 
concern of self-harm. This was carried out with the consent of the participant. No participants withdrew consent 
for the evaluation during the study. 
 
4.2.2. Sample group characteristics 
Table 2 below shows a comparison of the characteristics of the evaluation sample groups. Both groups illustrated 
similar age, previous history of medicated depression and co-morbidity characteristics. The standard care group 
consisted of proportionately more females than the intervention group. Data on family history of depression were 
confounded by a lack of data for standard care participants. 
 
Table 2: Sample group characteristics 
 Intervention group  
(sample n=80 unless specified) 
Standard Care group 
(sample n=40 unless specified) 
Age,  
median, min-max 
37, 18-69 42, 18-69 
Sex,  
% male (n) 
45.0% (36) 17.5% (7) 
Previous history of medicated 





Family history of depression, % (n) Yes: 73.7% (42)b 
 
Yes: 62.5% (5c) 
 
Number of co-morbidities, median, 
min-max 
1, 0-6 1, 0-9 
a In one participant previous medication for depression was not recorded in their medical records, leaving a sample of n=79 
for this variable 
b For twenty-three participants, family history of depression was not recorded in their medical records giving a sample of 
n=57 for this variable  
c Only 5 participants had this data recorded in their medical records in the standard care group 
 
Table 3 compares the evaluation sample group populations with both the total intervention population attending 
the new service in a similar period and all service users attending the practice for depression, low mood or anxiety 
including those on medication both at the walk-in clinic and those attending standard practice appointments 
during normal practice weekly hours. Apart from higher proportions of females in the standard care evaluation 
group as described above, evaluation samples were representative of service users both attending the 
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Table 3: Comparison of sample group characteristics to other GP practice populations 
 Total 
(n) 









Intervention group 83 47.0 17.3, 3-26 14.2, 1-21 1, 0-9 







122 42.6 16.4, 2-26 14.0, 1-21 N/A- data 
unavailabled 






Min., minimum; Max., maximum. 
aTotal number of patients attending Saturday clinic during the recruitment period 6/7/2019 and 1/2/2020 
b All patients presenting to GP practice between 1/7/2019 and 31/12/2019 for low mood, anxiety or depression including 
those on anti-depressants whether they attended standard appointments and/or the Saturday clinic 
c Data not routinely collected as part of standard care practice 
d Data not feasible to extract from practice medical records.  
 
For the intervention group, over two-thirds (85.0%, n=68) presented as a clinical case using IAPT service definitions 
(PHQ-9 score of >= 10 and GAD7 score of >=8)39. Many attending the new service presented with severe 
depression and/or moderate anxiety (Figure 3). The mean PHQ-9 and GAD7 scores for the new service 
(intervention group only) at baseline were 16.99 (SD 6.019, min-max 3-26) and 14.01 (SD 5.179 min. 1, max. 21), 
respectively. Although there are no data to make presentation severity comparisons with the standard care group 
due to lack of comparative assessment in practice, Table 2 shows that both groups exhibited similar previous 
history of medicated depression. Just under half of the intervention group (48.8%, n=39) had no suicidal ideation 
as assessed by question 9 of the PHQ-9, with 25.0% (n=20) indicating suicidal thoughts on more than half of the 
days or nearly every day in the last two weeks.  
 
Figure 3: Severity of depression and anxiety assessments at baseline for the intervention group (PHQ-9 and GAD-7 scores) 
 
Figure 3 shows the severity of participant depression and anxiety as measured by PHQ-9 score and GAD7 score, 
respectively.  Severity is assigned by scores for the PHQ-9 (depression) and GAD-7 (anxiety) symptom questionnaires and 
depicted from left to right above where: >15 is severe (orange), 11-15 is moderate (crimson), 5-10 is mild (green), 0-4 is 
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4.3. What impact has the systematic pathway had on service user 
experience and outcomes? 
4.3.1 Service user experience of the care pathway 
 
Participants rated the new walk-in clinic intervention highly. Comparison of participants between intervention and 
standard care groups indicated significantly higher satisfaction for those receiving the intervention (Table 4). Data 
from the intervention group service user experience questionnaire conducted at the six month visit indicated that 
95.5% (n=43) of participants were happy with the care they received (answered strongly agree or agree to the 
statement: ‘I am happy with the care I received at the walk-in clinic’). Qualitative data supported these findings 
indicating high satisfaction with the service as detailed in Table 5. 
 
Table 4: Comparison of service user experiences between sample groups – data collected at Visit 2 (6 months) 
 
 
  Service user experience 
 
Intervention group (n=46) 
n (%) 
 





Fell short of expectations 6 (13.0) 20 (51.3) <0.001 
Just met expectations 14 (30.4) 11 (28.2) 
Exceeded expectations 26 (56.5) 8 (20.5) 
 
Table 5: Qualitative interview findings on service user experience 
Theme Illustrative quotes and other supporting infomation 
Meeting expectations:  
The majority of service users 
were highly satisfied with the 
service; felt that service met or 
exceeded their expectations 
“[I]t absolutely exceeded my expectations because I wasn’t planning on walking 
away with a really quite awesome care plan and the service I received having seen 
two different professionals from different sides of depression treatment within 
twenty minutes of each other and walking out feeling very positive that it was 
going to have a very beneficial effect for me” (SU04b) 
 
“[I]t definitely exceeded my expectations because it was like a wrap around care…” 
(SU41) 
Clinic surpassed their 
expectations compared to what 
they normally experience during 
general GP appointments or care 
previously received for 
depression 
“100%. Yeah, I think it’s much much better than any other service I’ve had around 
mental health.” (SU59) 
 
“To be quite honest I had no expectations in fact I thought I’d be disappointed 
because I though it’s a brilliant idea but it’s not going to work. The NHS as I said 
before has let me down, let my son down [who died by suicide]. So I actually had 
no expectations and so it had to exceed it. [Laughter] No matter what…and by far 
                                                          
 
 
b Quote attributions starting with ‘SU’ (e.g. SU04) denotes service user interviews, ‘KI’ stands for key informants, including operational and managerial 
clinic staff, and ‘WS’ stands for wider stakeholders. Interviews with key informants and wider stakeholders are also marked with T1 (referring to the first 
wave of data collection soon after the clinic started) and T2 (denoting interviews 10 months after the start of the clinic).  FG1 refers to focus group with 
operational staff and FG2 refers to a focus group with managerial staff at the clinic. Joint interviews with multiple wider stakeholders have two participant 





Page 20 of 70 
 
it has. It’s given me faith again that people do know what they’re talking about” 
(SU36) 
Reasons for symptom improvement:  
Services users and clinic staff 
usually related improvement 
near-exclusively to the help they 
received at the clinic and 
receiving support from 
multidisciplinary team 
“I can safely say it is absolutely down to accessing the clinic because since then my 
grandmother’s passed away and I haven’t had an episode again, nothing like what 
happened because I’ve now got the tools and the access and the support that I 
think I need, mechanisms in the way that I deal with bereavement and all of that 
that it hasn’t manifested itself in a manic panic sort of episode” (SU45) 
 
“I would say a majority of the clients that I saw in the clinic that went on to have 
therapy, probably recovered at a quicker rate…or made some improvements” 
(KIO6T2) 
Service users welcomed having 
access to multiple types of care 
within a single clinic 
When asked if participants were happy to have access to other care services like 
One You and IAPT in one place, 76.8% (n=33) strongly agreed or agreed. 
Concerns around anonymity:  
While concerns were relatively 
infrequent, an area of particular 
concern was around the walk-in 
nature of the clinic.   
 
A small number indicated that 
this may be due to feeling 
exposed and potential loss of 
anonymity. 
67.4% (n= 28) of participants strongly agreed or agreed that they were concerned 
about attending a walk-in service. 
 
“I felt really sorry for this bloke I sort of know, who was plonked in the corner 
looking really glum and he’s sort of someone I only know to say hello to, I don’t 
know him well but obviously he’s there because he's feeling down and so am I, so 
it was really awkward and I’d sat down almost right next to him without looking 
that it was him, noticing who he was, so I suppose he felt really uncomfortable 
which made me feel uncomfortable, so yeah, it would have been better maybe in 
a mixed waiting room” (SU66) 
 
 “So everyone’s coming in for their depression low-mood clinic, everyone’s sitting 
there, it’s not very confidential then is it? You know, if I’m sitting there and if I was 
living in Faversham and I was kind of sitting there and I can see my neighbour 
sitting there as well, you all know why you're there” (WS08)  
 
“[S]he [service user] said the first Saturday she came in she saw who was at 
reception, she knows them…she came into the building and then she left because 
actually she didn’t want people to know …” (FG02T1) 
In contradiction, some service 
users said that placing the clinic 
at the GP surgery helped to 
address stigma around mental 
illness which may hold some 
people back from seeking 
support, and helped service users 
to maintain confidentiality 
around their difficulties 
 
“[I]t’s quite comforting when you’re in the reception area and you see there’s lots 
of people coming and going and they all look perfectly normal and you think, well 
there’s lots of normal people out there like me who are going through similar sorts 
of thing and not that I ever talk to someone, but just to look at someone or smile 
at someone or whatever, it’s just, it’s just like it almost gives you a sense of not 
feeling quite so isolated of weird or exposed” (SU54) 
 
“I think the biggest problem in life we suffer is the stigma against mental health 
and I think the one of the benefits of it being a doctor surgery is the fact that if you 
are embarrassed or you have got the stigma it’s a shameful thing no one knows 
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4.3.2. Service user experience of i-spero 
On average, participants logged in to use i-spero 22 times or approximately once a week (min-max 2-150 equating 
to nearly once a day). Just over half of participants used i-spero less than or once a week (56.4%, n=47), one third 
of participants (37.2%, n=31) used the technology two to three times a week and a small minority more frequently 
(6.0%, n=5 used i-spero more than three times a week).  
 
The majority of participants were happy to use the i-spero technology to guide their care and management (Figure 
4). Participants also found i-spero easy to use and 87% (n=40) indicated that they would use the technology again 
if it was offered to them. Participants did not experience problems with their internet connection (65.9%, n=29) 
nor found it difficult to access i-spero (65.1%, n=28) on their relevant hardware (computer/phone/tablet). One-
third of intervention group participants (34.8%, n=16) did not feel worried that other people (referring to 
professionals) may access the information collected about them in the i-spero web application. Participant views 
of i-spero from qualitative interview data are described in Table 6. Suggestions for improvement or development 
of the i-spero technology provided by service users in interviews are summarised in Appendix 6. 
 
 
Figure 4: Service user experience of using i-spero in their care pathway 
 
 
Figure 4 shows the responses to a service experience questionnaire completed by participants in the intervention group at 
the six-month visit (n=46). Data relating to the questions asked on the y-axis are displayed with respondents asked to 
answer whether they Strongly agree (blue), Agree (green), Neither Agree nor Disagree (red), Disagree a bit (yellow) and 
Strongly Disagree (black). 
 
Table 6: Qualitative interview findings on i-spero use 
Theme Illustrative quotes and other supporting infomatoin 
Ease of i-spero use:  
Service users  found i-spero 
straightforward to use and clinic 
staff felt that i-spero enabled 
service users to visualise their 
progress 
“Yeah, I really like it. I think it is a fantastic tool and I think it does need to be 
nationalised” (SU29) 
 
“Although [service users] didn’t feel necessarily that things were better…actually 
it illustrated the point of view from where they were a year ago, or six months ago, 
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“You just need to look at the scores and you can see people are improving… I think 
that’s actually boosting the confidence of the staff because they can all see that, 
and it makes them feel proud that they are helping people” (FG02T1)   
The only aspect which attracted 
substantial negative remarks in 
terms of ease of  use was the 
number and length of 
questionnaires within the i-spero 
technology 
Despite over half of intervention group participants (56.5%, n=26) disagreeing 
when asked if there were too many questionnaires to do in i-spero after six 
months of care, the length of the PReDicT test15 within i-spero in particular was 
seen as a barrier: 
 
“[T]hat was the only one that I did think will it ever end?” (SU03) 
 
“The faces test, which is the test that's the most useful test to predict the 
medication, is very long for patients. I get a lot of feedback from people that it’s 
too long” (FG02T1)  
 
“A few of the problems we’ve had on the ground level is the patients are getting 
very frustrated with the length of it. We’ve had quite a few patients complaining 
at the beginning that they’re just fed up doing it” (KI02T1)  
Difficulties around access and potential exclusion:  
Operational staff and wider 
informants identified that i-spero 
was not being used by some 
service users due to the way 
mental health symptoms 
affected their attention and 
other aspects of cognition, as 
well as lack of digital familiarity 
“Some of them are a little bit confused as to why they’re looking at faces or what 
they’re supposed to be doing in the test or how it’s supposed to help them. I think 
some of them genuinely don’t know why they’re doing it. Some of them do have 
an idea but don’t really understand how it’s going to help them” (KI06T1)   
 
‘The mental state that she was in trying to learn how to use an app. In that state 
of mind, she would not have been able to do it…I think the app would maybe work 
for people with mild levels of depression and anxiety, and that are in a place where 
they have the ability to think straight and be able to utilise something like that.” 
(WS04-05) 
Compulsory use of technology 
led to potential exclusion of 
certain service user groups (e.g. 
some service users remarked 
that the interface may be less 
intuitive for people not used to 
apps and digital assessments) 
“I’m nearly 60 but I think somebody who’d be a lot older than me maybe would 
find that quite difficult, you know, maybe somebody in their 70s or even 80s might 
find something like that quite difficult” (SU48) 
 
“I’m very lucky I'm of the age that we are used to that level of technology so that 
was fine. It wasn’t anything different to the normal kind of things that you would 
find in apps and online things in the work place so that was really good” (SU03) 
 
Length of i-spero use:  
The majority of service users 
continued to use the app at the 
point of the initial call and many 
were still using it to track change 
in their depression at six-month 
follow-up 
“I use the app kind of weekly or sometimes once a fortnight just to kind of monitor 
where I am but also what’s been really helpful for me is to use it to see because I 
had to change the medication so I’m now on my third medication. It’s just been 
really useful to see how effective or not effective the medication is” (SU03 at six-
month follow-up) 
 
At initial interview as well as at 
six-month follow-up, some 
service users reported no longer 
using i-spero. 
Ceasing to use i-spero was attributed to log-in issues, access issues, length of 
assessments or because their symptoms improved to the degree they no longer 
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“’I’m not really using the online features any more but I am still taking medication 
[…]  I think the app needed some refinement in terms of sort of […] making it more 
easy to log in and enter information.” (SU01 at six-month follow-up) 
i-spero score-based follow-ups:  
Some service users felt that the 
questionnaire items which 
determined suicidality alerts did 
not sufficiently differentiate 
between suicidal thoughts and 
suicidal intent 
"I guess the only thing would be as sort of a differentiation between that 
question and ‘do you have any intention to harm or kill yourself’, because 
then I think that would definitely require a response from the doctor. But 
it’s possible to think that it would be better if you weren’t here without 
necessarily being suicidal or intending to hurt yourself. So I guess from that 
respect just making that a bit more, that question a bit more explicit, 
because every time I filled it in it was like I know in about two hours I’m 
going to get a phone call. (SU33) 
More general follow-up checks 
based on deterioration of scores 
were highly appreciated by 
service users, some of whom felt 
they would not have shared how 
they felt without the scores 
“So I’ve had a phone call from her before when she would say “right, how 
are you?” and I say “fine” and she’ll say “well looking at your last test 
results you don’t seem to be feeling fine, do you want to talk to me about 
that?” […] So she planned and prepped for that phone call to know that I 
wasn’t alright, and she already knew that so she didn’t really have to take 
my “yeah, I’m fine” for granted because she could rely on another 
resource” (SU47) 
 
4.3.3.  Service user outcomes 
 
4.3.3.1. Comparison of outcomes between groups at six months 
Table 7 illustrates that participants in the intervention group exhibited significantly lower depression symptoms 
when compared to the standard care group after six months of care. No difference in anxiety symptoms nor 
measurement of changes in service user wellbeing were observed as statistically different between the groups. 
Differences in severity of suicidal ideation (indicated by responses to question 9 of the PHQ-9 symptom 
questionnaire) between the groups after six months was of borderline significance (p=0.053, Pearson’s chi-
squared test). A tenth of participants (12.8%, n=6) in the intervention group responded as having self-harm 
thoughts on more than half the days or every day compared to a third (30.0%, n=12) in the standard care group. 
 
Table 7: Comparison of service user outcomes between sample groups at Visit 2 (six months) 
 
Outcome measure at 




Mean (SD) (n) 
Standard Care 
group 
Mean (SD) (n) 
p-value 
(Independent sample T-test) 
PHQ-9 total score  11.6 (7.57) 
(n=47) 
14.5 (6.53)  
(n=40) 
0.047 






ICECAP-A total tariff  
0.693 (0.22) 
(n=46) 
0.622 (0.19)  
(n=39) 
0.122 
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4.3.3.2. Service user outcomes over time – intervention group 
Table 8 illustrates that participants in the intervention group showed significant improvement in symptoms over 
time for symptoms of depression (PHQ-913), anxiety (GAD714) and wellbeing (ICECAP-A19). Severity of suicidal 
ideation as indicated by responses to question 9 of the PHQ-9 symptom questionnaire reduced significantly over 
time from a baseline proportion of 24.0% of participants (n=20) responding as having self-harm thoughts on more 
than half the days or every day, to 12.8% (n=6) at six-months post-baseline (p=<0.001, Pearson’s chi-squared test). 
To add clinical context, 35.4% of participants in the intervention group exhibited recovery as defined by reduction 
in PHQ-9 and GAD7 symptom scores to below clinical case definition (PHQ-9<10 and GAD7<8) at the six month 
timepoint39. Clinically relevant improvement was observed for 59.6% of participants in the intervention group, 
classified as a reduction in PHQ-9 score of 5 points of more39. National NHS targets for IAPT services alone aim for 
half of service users to be classified as in recovery and two-thirds experiencing reliable symptom improvement 
after a course of IAPT treatment39. The achievement of these targets vary across the country but have been met39. 
Reports of improvement from participant interviews gave additional detail about how and why improvement 
occurred as described in Table 9. 
 











(repeated measured ANOVA with 
Bonferroni correction) 
PHQ-9 total score (47) 18.3 (5.67) 12.6 (6.61) 11.4 (7.57) <0.001 
GAD7 total score (47) 14.5 (4.50) 10.7 (6.10) 9.9 (6.69) <0.001 
ICECAP-A total tariff (46) 0.570 (0.19) 0.642 (0.18) 0.693 (0.22) <0.001 
SD, standard deviation. 
 
Table 9: Qualitative findings on symptom improvement and wellbeing 
Theme Illustrative quotes and other supporting infomatoin 
Symptom improvement:  
Most service users reported symptom 
improvement, as well as an increased 
sense of wellbeing after attending the 
clinic.  
 
“I’m infinitely better than I was when I first, you know, when I first went in 
October I was really low and it stayed low for quite a long time, and you 
know, the last month or so you know, things have really improved” (IDC33) 
 
“Even just playing with my children is much easier because my head’s clearer. 
I’m not feeling down, you know, as if the world’s crashing in on me. It means 
that I can get up and face it” (SU69) 
 
A fluctuation in symptoms during follow up was not uncommon, but many 
reflected that at six months their symptoms did not worsen and timely help 
from the clinic usually resulted in improvement. 
There was a strong perception by 
clinic staff that service users improved 
or recovered at a faster rate than 
would have occurred without the 
clinic.  
 
This was in part, due to having a dedicated multidisciplinary service:  
 
“I would say a majority of the clients that I saw in the clinic that went on to 
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“Because people feel like they are being listened to. That there is this service 
that really cares about them, and it's there for them. That I think aids their 
recovery…so I do actually think the clinic does play a role and people feel they 
are supported and they can be okay” (KI06T2)  
While for some, symptom 
improvement occurred soon after the 
initial visit to the clinic, for others this 
was a considerably longer process. In 
circumstances of worsening of 
symptoms at six-month follow-up 
interviews, these were usually 
temporary and where setbacks 
occurred, the remote monitoring via 
the i-spero app was seen as crucial in 
enabling a timely delivery of care and 
resulted in a quick recovery 
“I unfortunately had a relapse back in December and Dr. [name] at the clinic 
instantly spotted my scores. I went in that next weekend and she was 
expecting me because she knew my scores had gone down from looking 
through the app and she was just absolutely fantastic. She really was 
brilliant. Really, really supportive and I’m back on a very positive track again” 
(SU04 at six-month follow-up) 
 
Changes to wellbeing:  
Many participants reported a sense of 
wellness at the point of the initial 
interview. They mostly attributed the 
ability to feel well to the help received 
at the clinic, suggesting that the clinic 
was able not only to help with clinical 
symptom relief, but also meet service 
user own goals 
“Prior to going to the clinic in November, work was my life and it was a case 
of chucking myself into work, but then I’d come home and I’d just get straight 
into bed just because I had no motivation to do anything, I wasn’t seeing 
friends, I wasn’t seeing family, I wasn’t talking to my housemate, it was just 
a case of just come in, go to bed, get up, go to work. […] it’s [down to] 
everything that the clinic has given me, but also supported me in being able 
to engage with again” (SU46) 
For many, rather than being 
symptom-free, being well meant 
ability to engage in activities 
meaningful to the individual (e.g. 
socialise or return to work), as well as 
being in the moment and ability to 
enjoy at least some aspects of life 
“Being well mean being able to get up without a kind of screaming in your 
head without having to really talk yourself into the day and it means that I 
can do the job that I do and operate and…and be in the moment rather than 
being detached from everything.” (SU03) 
 
“Still hav[ing] enough energy to live my life. So whether that be through work, 
energy to go out and exercise…and to literally sort of be with family and 
friends. Very simple really…” (SU41) 
While experiencing some 
improvement, a small proportion of 
the interviewees nonetheless felt that 
this improvement was not sufficient 
for them to feel ‘well’ 
 
“I’ve got a long way to go but I definitely, I’m not at the place where I was 
when I thought that no-one was going to do anything and that this was all 
pointless. I’m definitely not at the start of the journey, put it that way, and I 
think it’s just a matter of time and just sticking with it. And it’s one of them 
things, it’s not going anywhere anyway, it’s going to be with me forever, so 
I’ve got plenty of time to master it” (SU47) 
Where symptom alleviation was 
spoken about as the key to wellness, 
the importance of addressing 
symptoms remained around being 
able to engage in everyday life/tasks 
“I couldn’t drive, I could hardly speak, I couldn’t even go to my own house you 
know I had to stay, I had to be with my mum, and I’m an adult! I couldn’t 
function on my own, I needed somebody to be with me […] So being well is 
just, is being able to function day-to-day without having symptoms of 
anxiety, severe symptoms of anxiety.” (SU45) 
 
It should be noted that wider life circumstances played an important role in symptom improvement for a number 
of participants, including the psychological impact of the COVID-19 pandemic (see section 5.5 for COVID-19 
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some participants specifically spoke about the clinic – and symptom tracking helping them deal with life 
circumstances and change. 
 
There was a clear indication that the intervention enabled participants to better manage their symptoms. Figure 
6 shows that the use of the i-spero technology supported care management with over half of participants 
reporting that using i-spero made them feel more confident about the care they were receiving and treatment 
plan (58.7%, n=27 responding strongly agree or agree). Furthermore, participants valued the ability to use the 
technology at home but also felt that it was important for them to make time to use i-spero and that this time 
was not difficult to find in their daily lives. 
 
Figure 6: Service user experience of i-spero in supporting care and management of symptoms.  
 
Figure 6 shows the responses to a service experience questionnaire completed by participants in the intervention group at 
the 6-month visit. *Total respondents to each question is n=46, except for the question relating to use of i-spero technology 
at home where the sample total is n=45. Data relating to the questions asked on the y-axis are displayed with respondents 
asked to answer whether they Strongly agree, Agree , Neither Agree nor Disagree, Disagree a bit or Strongly Disagree. 
 
Participants in the intervention group reported statistically significant (p=0.011) improvement in joined up support 
and care (84.8%, n=39 answering sometimes or always experienving joined up care in the LTC-6 questionnaire at 
the six-month time point) compared to the control group (65.8%, n=25). The majority of participants specifically 
related an improvement in depression (and/or anxiety) symptoms to the holistic, multifaceted help they have 
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Approximately two-thirds (60.9%, n=28) of the intervention group participants felt more supported to manage 
their own health in comparison with 18.4% (n=7) of the standard care participants (p=0.001) after six months of 
care. Despite feeling more supported, there was no change in how confident participants felt about managing 
their own health (p=0.357) with 71.7% and 67.6% of participants responding that they were somewhat or very 
confident in the intervention group and standard care group, respectively. Similarly, no difference in samples was 
observed when participants were asked if they were involved as much as they wanted to be in decisions about 
their care between groups (p=0.168). Those in the intervention group did experience better discussions with clinic 
staff about the most important elements for managing their own health (p=<0.001) and had better experiences 
of receiving enough information to help them manage their health when compared to standard care group 
responses (p=0.017). Table 10 shows qualitative data supporting the participants’ sense of improved 
management. 
 
Table 10: Qualitative findings on clinical management and self-management 
Theme Illustrative quotes and other supporting infomation 
Clinical management and self-management:  
Service user participants frequently 
spoke about how the clinic helped 
them to self-manage their anxiety 
and/or depression and identified that 
having a choice of treatment options, 
seeking and taking up help offered in 
a timely manner and agreeing a plan 
of action on how to monitor illness 
progression were important 
“[W]hen I first went I was very like uncertain and unsure and I didn’t know 
where I was going or what I needed. Where as now I know I just need sort of 
like…a little call from the doctor every now to make sure my meds are ok. And 
apart from that I’m all right now” (SU29) 
 
“I think it’s because it’s been, you know, regular appointments and regular 
check-ins, so an element of self-stuff, but I think also it’s down to the fact that 
you’ve been seeing, and often seeing the same doctor which is helpful, you 
know, several times over a reasonably short period rather than just going 
back every six months or so” (SU33) 
 
“[T]hey also made me do things for myself. I wasn’t just led. I know I said I 
like being led but I know that that’s actually not a good thing you have got 
to take charge of your own life and they encourage you, and the little book 
they give you to say this is what I’ve done today or this is…” (SU36) 
Clinic staff particularly related the 
experience of using i-spero as 
supporting clinical management 
effectively 
“The PReDicT test is really useful because I think it absolutely does mean that 
we titrate medication differently so for me that’s obviously the big selling 
point with the tech but I actually do think that actually people do the 
questionnaires and you can see the results and their doing them in their own 
time at home is a very efficient way to deliver care” (FG02T1)  
 
“It really guides your prescribing when you see their scores, and it guides the, 
it guides the titration of medication based on the PReDicT test, so without it 
it’s so hard to do it” (KI01T1)  
 
“From a GP perspective, I think the apps brilliant and I think in terms of 
medication, monitoring, and seeing what the impact of any medication is 
having” (WS04-05)  
 
Over the follow up period, a total of 179 i-spero alerts were dealt with by the practice outside of the intervention 
clinic (Table 11). Two thirds of service user participants triggered a maximum of one symptom deterioration alert 
(PHQ-9 or GAD7 related) from the i-spero system that was acted upon by the clinical staff by either increasing 
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a suicidality alert; however, one service user triggered 13 suicide alerts alone. Qualitative data (Table 12) showed 
that although alerts were viewed as positively assisting with proactive management, they added additional clinical 
burden. 
 
Table 11: i-spero alerts triggered by participants and sent to the practice for clinical action during the participant 
follow up period of six months. 
Number of alerts from individual service users to the GP practice, 
n (%) 
Max alerts by any 
one service user 
(n) 
Total alerts from 
all service users 
(n) Type of alert 0 1 2 or more 
Suicidala 66 (79.5) 8 (9.6) 9 (10.9) 13 62 
PHQ-9 
deteriorationb 
25 (30.1) 58 (69.9) 0 (0.0) 1 58 
GAD7 
deteriorationb 
24 (28.9) 59 (71.1) 0 (0.0) 1 59 
Total alerts 179 
asuicide alerts are based on service user scores on Q9 of PHQ-9 answering nearly every day or thoughts of death or suicide 
within the QIDS-SR16 questionnaire of the PReDicT test,  
b PHQ-9 or GAD7 deterioration alerts are based on a reduction of <50% in scores recorded four weeks (or nearest score) 
after the first care plan added service. 
 
 
Table 12: Qualitative findings on alerts 
Theme Illustrative quotes and other supporting infomatoin 
Alerts:  
The alerts sent by the i-spero 
technology, including those triggered 
by symptom deterioration but more 
importantly the suicide alerts, were 
seen as positive in terms of being able 
to deliver pro-active care. However, 
the volume and non-specificity of 
suicide alerts was also seen by some 
as a nuisance, adding to workloads 
“So the service allows us to be a lot more proactive, so you’ve got the 
reminders from the technology which are pinging up…,so we call them 
proactively” (KI01T2) 
 
“Unless someone actively phoned us to say that they were suicidal, we 
would never have known that and therefore we would never have managed 
that. Now, I think the fact that we do know that and we can give someone a 
call is a good thing and maybe is something that you would hope we should 
be doing anyway” (KI03T2) 
 
“I think by having technology like this it does…it flags all our alerts. Now, 
that increases contact because I have to ring someone if I get at alert but 
does that mean that they then go and have an admission because they 
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4.4. What are the components of the care delivery model that are really 
making a difference? 
Seven key components or ‘active ingredients’ were identified that supported service provision, set out in Figure 
7. These are expanded upon in Table 13 below, which draws on qualitative data to illustrate the themes. 
 








Table 13: Active ingredients of the service supporting implementation and outcomes with evaluation evidence. 
Component Illustrative quotes 
Integration 
between the 
clinic, the app 
and service user 
involvement 
provided more 
holistic care and 
guided clinical 
management 
“The service provider, the service user and the technology together provide you with that glue and 
that integration that provides a more holistic, rounded management of care that, you know, can’t 
be done without those three things together” (WS01)  
 
“I really do like the technology, I find it really helpful to use alongside speaking to people, I think 
generally people feel, I think they really like it, I think they like monitoring themselves as well, it’s a 
positive thing” (KI01T1)  
 
“What’s good about it is, it isn’t just technology, you’re talking about technology complimenting a 




















Integration between the 
clinic, the app and 
service user involvement 
Options and choice 
available to service 
users 
Multi-disciplinarity 
Pathway champions and 
clinical leadership 





Flexibility (ability to 

















“From a GP perspective, I think the apps brilliant and I think in terms of medication, monitoring, 
and seeing what the impact of any medication is having” (WS04-05)  
 
“It really guides your prescribing when you see their scores, and it guides the, it guides the titration 
of medication based on the PReDicT test, so without it it’s so hard to do it” (KI01T1) 
Options and 
choice available 
to service users 





“I just felt that I wasn’t just left with a prescription and off you go…sort of deal with it. I very much 
like ok we want to assess you in four weeks’ time. We want to get the counseling started and then, 
only then are we happy to just…not letting you go but just sort of watch you.” (SU41) 
 
“They definitely met my needs. […] in the past I hadn’t had positive experiences with that and they 
were very quick to reassure that look, you know, give this a go and if it’s not working we can then 
very quickly change things up, so it was that notion of continuous care I think that was the thing 
that really sold me on it” (SU59) 
 
“[T]he first person you speak to is the doctor and she said she would advise it might be helpful for 
you to see this person but you could see this person if you wanted to and explained what they did 





and skill mix of 
professionals 
with an interest 




“Well from one room to another between the three different disciplines if that’s the right word […] 
So I felt that I was getting someone’s complete attention who understood the nuances of my 
condition and had the time to think about it if you know what I mean. I think that worked” (SU20)  
 
“I don’t really know what other professionals there could potentially be. As far as I'm aware you 
can go down the anti-depressant route, you can go down the talking therapies route or both like 
I’ve done and I…I wouldn’t know what else to expect. I wouldn’t know who else would be there…so, 
everyone who’s there is brilliant and they’re doing their job” (SU04) 
 
“We’ve got lots of clinicians, patients generally see a different clinician every time and quite often 
generally mental health isn’t the interest of many clinicians so it’s in and out, whereas you know, 
myself and [name] have got a lot of interest in it so you get more empathy, and I think those 
normal surgeries, they don’t have that feeling of it’s a clinic just for their condition” (KI08T2)  
 
“Dr. [name] is clearly very passionate about supporting peoples mental health and wellbeing and is 
prepared to put the time into enable that to happen and I think that that’s one of the reason why 
the clinic is so successful is that feeling of actually being really listened to and being really 
understood and then having that follow up at the time they said that it was going to happen just 





leadership as a 
driving force for 
the service   
“Because of their championship and leadership it has been relatively easy to actually get it 
implemented, up-and-running and being used (WS01) 
 
[The] overall experience has been very positive in terms of the team, I think everybody’s worked 
really well together, great leadership, everybody’s very supportive (WS01) 
 
“Having those champions within the GP setting I think is critical for it to be able to work… having a 




timely access to 
assessment and 
treatment 
“I think a lot of people who are feeling anxious or feeling low or depressed they’re not quite…they 
don’t want to make phone calls they don’t want to reach out. But being able to have a walk in 
clinic where you can just amble in there and go actually I’m not feeling very well. That, just being 











“I was able to just go when I felt I needed to as opposed to if you feel you need to and then the 
appointment sometime away whether that’s an hour away or a day away or a week away it’s not 
necessarily getting to you when you need it. I think that was important” (SU20)  
 
“[It] is quite nice in that I don’t have to book an appointment and see a GP and feel that I’m 
wasting their time by booking an appointment and then having to wait etc. It’s quite nice that you 
can just walk in if I wanted to. Equally I don’t have to if I don’t want to” (SU05) 
 
“The normal wait is six to twelve weeks. Sometimes so you can go away from a GP and know that 
you’ve still got another two months wait before they’re even going to see a counsellor” (KI02T2)  
IT support was 




“We provided a live help desk availability so we actually had people here in Pivotal working on a 
rota shift on the Saturdays to provide telephone support for any sort of emergency issues, any 
emergency, I know certainly for the first, for 2 to 3 weeks we actually had somebody from Pivotal 
in person at the clinic, so I think that really helped provide confidence for everybody in terms of 
making sure that the software did work… because of that live support that was provided right at 
the beginning, you know, if there were any issues or clarifications they were sorted out very 
quickly” (WS10) 
 
“The Saturday support was no longer required, you know, there was often many Saturdays where 
we had no calls at all [to the i-spero helpdesk]. I think for the last few weeks of that Saturday 
support there was hardly a call made, which was good, which meant that the clinic was running 
smoothly and the software was running smoothly” (WS10) 
Communication 








“I think it's fantastic. I think it's just from a service point of view. I think it's just taken a little bit of 
time to embed the pathway in a way that actually works” (WS04-05)  
 
“I wanted to make the social prescribing more depression anxiety related, as opposed to just 
general social prescribing, so originally we were talking about smoking cessation and weight loss, 
they were quite there in their social prescribing mindset. Some of the things that we discussed 
were around it very much being mental health social prescribing, so they definitely had the, they 
took that onboard in their approach and they changed the people delivering it, and their approach 
has definitely improved and they were utilising like the Umbrella Centre, they were utilising Visit 
Gardens, so using some of the Mind stuff within the community much better”  (KI01T1)  
 
“So I think in terms of that initial phase and that initial rollout, I think it was very positive and I 
think we’ve had good communications between us all, in terms of the regular meetings that we 
have, the quarterly meetings and the regular updates that we have between us to understand how 
the clinic was working, how certain processes and methods could be improved to provide greater 
efficiency …” (WS10) 
 
“I think one of the big things was the i-spero application was designed around being a patient 
application but what we found increasingly was that because of various situations, it would help 
the efficiency of the clinic sort of allowing the GP to edit certain things on behalf of the patient, so 
one of the things that was flagged was the ability to edit and update care plans on behalf of the 
patient” (WS10)  
 
“The patients actually wanted to see the score and so the clinicians thought it was a good idea for 
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4.5. How have contextual factors affected implementation and outcomes? 
A number of local and national factors were perceived to influence implementation and sustainability. Table 14 
uses qualitative data to set out the identified contextual factors that had a significant impact on the delivery and 
implementation of the new service pathway. These contextual factors also consider elements that impacted on 
participants and their outcomes. 
 
Table 14: Contextual factors affecting service implementation and outcomes  
Description of context and impact Evidence 
Commissioning landscapes: 
Changes to the commissioning landscape, 
with respect to the merger of Commissioning 
Groups in Kent and Medway, caused concerns 
about the sustainability of the service in the 
long-term. Having Commissioner 
representatives involved in the design of the 
new service at the start, sitting on the project 
steering committee and linking to mental 
health commissioners in particular helped 
ensure the outcomes of the new service 
remained centre-stage. 
 
The different geographical service footprints 
limited the reach of services within the clinic 
e.g. IAPT service footprint. Also, the fact that 
the service was limited to two medical 
practices meant it could not be offered to all 
service users within the larger region resulting 
in a ‘2-tier’ service as highlighted by wider 
stakeholders. Service provision boundaries is 
something that would have to be addressed 
for scalability. 
“It’s now being approved going to Kent and Medway as a CCG so 
that completely changes our footprint now…we’re slightly further 
removed but…I think we’ve got it on the agenda when we needed to 












“I think the biggest problem is this is just Newton place and 
Faversham Medical Centre taking part and we operate in Swale as 
well which doesn't include those. So first, it's very limited because we 
can only use it for those particular clients” (WS06-07)  
 
  
Primary care service demand: 
Demand in the system for primary care and 
other services created problems for delivery. 
 
 
“We are getting more and more people register everyday with us. 
We’re not getting any more staff so it’s generally just something 
we’re facing as a surgery anyway…the clinic hasn’t increased that a 
massive amount…in the grand scheme of things it’s not a lot when 
actually we’re sort of completing fifty registration forms a week 
anyway for [new] patients” (KI02T2)  
Demand on regional mental health services: 
High demand on regional mental health 
services impacted on the ability to recruit a 
Clinical Psychiatric Nurse which was felt to be 
an important addition to the specialist skills 
within the clinic and meeting needs. 
“Finding a CPN has been an issue so getting the staff we originally 
wanted has not worked and I think we’ve had a lot of conversations 
we’ve tried everything but there just isn’t the CPNs around or people 
that want to do it so that obviously has impacted” (FG02T1) 
 
BREXIT: “I know the Brexit situation has been kind of discussed in the surgery 
between different teams and different staff but it could potentially 
have an impact on us…because Faversham is under the…I can’t 
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More broadly, Brexit created a high degree of 
uncertainty in terms of staffing and 
maintaining the service. 
 
know how that’s going to affect staffing or anything else actually at 
this point” (KI06T1) 
Severity of service user presentation : 
The majority of service users presenting were 
experiencing moderate or severe depression. 
This put more demand on GPs within the 
intervention which was not intended 
originally. The level of severe depression 
impacted on staff time, intervention costs, 
emotional burden for staff and service user 
readiness to engage in services. As a result 
the service had to adapt quickly. 
 
Evidence suggested there was an opinion that 
mental health needs were not being met 
locally, particularly those with severe anxiety 
or depression not getting the help they 
needed from current mental health services 
so the clinic provided a vital service.  
 
“I definitely think we’re still getting quite the severe ones and I think 
that’s because there’s just a lack of community mental health 
services available so these patients are just getting lost. And so, 
because we’re giving them that dedicated time, they’ve got some 
wrap-around care, they’ve got the app to support them… So I think 
they’ve fallen through the gap and I think this has just provided that 
bridge between standard primary care and community mental 
health team. Which is why I think, actually, we’ve probably got quite 
a lot of the severe coming through. But mental health services are 
just poor, they’re so poor locally and it shows it, I think” (KI02T1)  
 
“There were some clients who genuinely, probably should be under 
secondary care services. So for those ones, it was a case of I had to 
try and grab a GP where I can and ask them to refer because we 
don't technically really refer to secondary care services anymore. 
That has to be the GP. So it kind of felt a little bit like oh, am I 
wasting the client's time here. Now they’ve got to wait around and 
see the GP and I’ve got to ask the GP to do this. And I felt like there 
wasn't really a structure in place for clients that were probably 
above the expectation” (KI06T2)  
COVID-19: 
Unsurprisingly, the Covid-19 pandemic had a 
significant impact on the delivery of the clinic. 
The number of referrals to the clinic saw an 
initial drop due to fewer contacts between 
clinicians and people with mental health 
needs.  This resulted in reduced waiting times 
for those willing to engage with some services 
within the clinic, e.g.IAPT, during the 
pandemic. Use of i-spero was particularly 
helpful for remote consultations. The shift to 
telephone appointments as a result of COVID 
was not deemed preferable for service users.  
Service users felt the clinic offered a life-line 







As a result of this shift to remote 
consultation, we looked at changes in the 
number and type of appointments before and 
after the onset of COVID-19.  
“In terms of our waiting list as an IAPT service, people are actually 
being seen quicker than they were. Because where everyone's 
working remotely at the moment, it seems like being able to fit 
people in because we're not relying on room space, or we're relying 
on you know, therapists traveling in between locations and stuff like 
that” (KI06T2) 
 
“In this world with all the remote stuff, it’s [i-spero] even more 
helpful, so you can’t see the patient, but actually I can see their 
scores, and I can see how things have been running, and so it’s easier 
to do a telephone consultation when you’ve got all that information, 
it’s hard to do a consultation without it” (KI01T2)  
 
“No, it's definitely all down to the clinic and the offers available to 
me. And I think certainly without all of that that I've had with COVID-
19 with the job loss with the half out of work now; we’ve had to 
cancel our wedding that we've been planning for three years, I think I 
would have reached an all time low. So, the first week of all this 
starting yes, I was very anxious, but I never had the attack because it 
was almost like, I knew I was getting that questionnaire and I knew 
that the results would give me an indication of what I needed. So, no, 
it's been great for me” (SU71) 
 
Aligning with the government timelines whilst being considerate of 
the progression of those using the new service (i.e. just started using 
the service or using it for a while), we defined the following periods: 
(a) pre-lockdown (1st January 2020-15th March 2020) and (b) 


















the end of July to account for those shielding. In the pre-lockdown 
period, 71 appointments were recorded in total for those in the 
intervention group. Of these, 57 (80%) were with a GP, 2 with a 
nurse practitioner (3%) and the remaining 12 (17%) with OneYou 
services. In the lockdown period, 42 appointments were recorded in 
total for those in the intervention group, primarily with a GP (88%) 
and a few (12%) with a nurse practitioner. Overall, 32% of 
appointments took place over the phone in the pre-lockdown period 
compared with 90% during lockdown. Interestingly, appointments 
lasted about three minutes longer, on average, prior to lockdown 
than during lockdown. However, this duration also includes the time 
taken to type notes, which may not be an accurate reflection of the 
actual service user contact time. In cost terms, assuming that a GP 
phone consultation costs 40% less than a face-to-face consultation29, 
this would translate to a total cost of £1,908 for all GP consultations 
pre-lockdown compared to £697 during lockdown, equivalent to a 
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4.6. How have changes to resources/activity impacted costs? 
4.6.1. Saturday clinics 
In the intervention group, 288 Saturday appointments were recorded in total, of which 197 (68%) were with a GP, 
36 (13%) with OneYou and 55 (19%) with IAPT. GP appointments lasted 17 minutes on average which was 
significantly longer than OneYou and IAPT appointments (9 and 10 minutes respectively). This is not surprising, 
however, as GPs were the main point of contact when the service user firstly attended the Saturday clinic – they 
were responsible for assessing the service user’s depression severity and for triaging them to the relevant services. 
Each time a service user presented at the clinic, they saw one health professional on average, which does not 
necessarily imply that the remaining services were not offered to them on the day. Instead, it may be that either 
due to time constraints (for example, clinic ran for half a day) these appointments were scheduled for the following 
Saturday or another day during the week or that it was just a follow-up appointment. Indeed, for some service 
users only an IAPT, OneYou or GP appointment (latter over the phone) was recorded on a Saturday. Overall, an 
appointment was recorded on three Saturdays on average per service user. Table 15 shows the average cost of 
each of the different components that were used to calculate the cost of Saturday clinics. These are only applicable 
to the intervention group.  
 
Table 15: Average costs of Saturday clinics (intervention group) 
 
Costs (£) Mean (SD) Min. Max. 
Reception 60.64 (43.35)2 7.73 246.12 
Management 12.18 (10.98) 0 55.28 
GP 57.92 (38.29) 0 222.84 
Nurse1 n/a n/a n/a 
IAPT 13.91 (18.31) 0 60.76 
OneYou 7.29 (19.23) 0 109.74 
 
Additional costs associated with: 
Reception (overtime) 2.97 (2.07) 0.50 11.64 
Management/Management 
admin/GP sessions 
51.94 (35.52)  11.99 222.67 
n/a, not applicable; SD, standard deviation; Min., minimum; Max., maximum. 1 No Saturday appointments with a nurse were 
recorded in the health economics study sample. 2 We were unable to separate the actual reception time spent on running 
the Saturday clinic from the time spent on other research activities, thus this may be an upper bound of the true reception 
time. 
 
4.6.2. Health and social care resource use 
Table 16 shows the average resource use per service user in each group observed in the data for the complete 
cases only (i.e. 40 service users in the standard care, group; 44 service users in the intervention group). 
Participants in both study groups had one GP appointment on average at six months. This did not include contact 
with professionals responding to i-spero deterioration or suicidality alerts which were not included in this analysis. 
Amongst all community-based services, and perhaps not surprisingly given the nature of the study participants, 
talking therapy was most frequently used amongst both study groups, with participants in the intervention group 
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group. The use of support or self-help groups was also reported, albeit somewhat less frequently by those in the 
standard care group. Any further conclusions should be tempered given that very little was reported in the follow-
up assessments. 
 
Table 16: Average resource use per participant by study group (complete case) 
Service  








Standard Care group 
(n=40) 
Primary care 
GP (face-to-face/phone)  2.22 (2.11), 0-8 1.23 (2.06), 0-9 0.97 (1.51), 0-7 
Nurse practitioner 0 (0) , 0-0 0.07 (0.25) , 0-1 0.10 (0.30), 0-1 
Mental health worker/nurse 0 (0), 0-0 0 (0), 0-0 0.05 (0.32), 0-2 
OneYou 0.48 (1.05), 0-3 0.25 (0.69), 0-3 0 (0), 0-0 
Community-based 
Community mental health centre 0.18 (0.50), 0-2 0.27 (0.95), 0-4 0.08 (0.35), 0-2 
Group therapy 0 (0), 0-0 0 (0), 0-0 0.08 (0.47), 0-3  
Talking therapy 1.30 (2.25), 0-11 5.39 (6.75), 0-30 3.13 (6.10), 0-26 
Social care-based 
Occupational therapy 0.11 (0.44), 0-2 0.02 (0.15), 0-1 0 (0), 0-0 
Service user support or self-help 
groups 
0 (0), 0-0 0.52 (2.03), 0-10 0.05 (0.22), 0-1 
Dietitian 0 (0), 0-0 0.05 (0.30), 0-2 0 (0), 0-0 
Hospital-based (inpatient) 
Acute psychiatric ward 0.23 (0.15), 0-1 0 (0), 0-0 0 (0), 0-0 
Psychiatric emergency/intensive 
care/crisis centre 
0.05 (0.21), 0-1 0.02 (0.15), 0-1 0.03 (0.16), 0-1 
Hospital-based (outpatient) 
Psychiatrist 0.23 (1.51), 0-10 0.11 (0.49), 0-3 0 (0), 0-0 
Occupational therapist 0 (0), 0-0 0.02 (0.15), 0-1 0 (0), 0-0 
 
SD, standard deviation; Min., minimum; Max., maximum. 
Note: The following services were not reported by any of the service users: day care centre (community-based), social worker 
(social care-based), psychiatric rehabilitation ward (hospital-based, inpatient), psychiatric long-stay ward (hospital-based, 
inpatient), psychologist (hospital-based, outpatient). 
 
Mean health and social care costs broken down by type of service, study group and for each time point are 
presented in Table 17. With or without imputation, health and social care services costs are significantly higher 
for the intervention group than for the standard care group at six months, which is consistent with more frequent 
use of related services by the intervention group in the same period, discussed earlier on the reported resource 
use. There are no significant differences in hospital services costs and medication costs between the intervention 
and standard care group. Looking at differences in medication costs over time, it seems that in the intervention 
group stronger and/or more diverse medication was prescribed within eight weeks, as the medication costs were 
almost eight times higher on average during that period than at six months. This may also coincide with severely 
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Standard care group 
(n=40) 
Health and social care services costs (excluding costs of Saturday clinics) 
Mean (SD) 195.65 (181.72) 396.01 (422.01) 230.88 (378.83) 
Min. 0 0 0 
Max. 933.00 1,683.00 1,458.60 
Hospital services costs 
Mean (SD) 25.96 (123.08) 11.99 (40.92) 5.53 (35.00) 
Min. 0 0 0 
Max. 690.55 221.35 221.35 
Medication costsa 
Mean (SD) 16.85 (78.51) 2.50 (2.13) 3.08 (3.38) 
Min. 0 0 0 











Standard care group 
(n=40)c 
Health and social care services costs (excluding costs of Saturday clinics) 
Mean (SD) 198.61 (178.10) 286.04 (366.07) 230.88 (378.83) 
Min. 0 0 0 
Max. 933.00 1,683.00 1,458.60 
Hospital services costs 
Mean (SD) 18.05 (98.21) 7.72 (32.78) 5.53 (35.00) 
Min. 0 0 0 
Max. 690.55 221.35 221.35 
Medication costsa 
Mean (SD) 19.89 (96.40) 2.27 (1.99) 3.08 (3.38) 
Min. 0 0 0 
Max. 625.61 11.24 10.65 
SD, standard deviation; Min., minimum; Max., maximum. 
aMedication costs in the intervention group were not imputed. 
bOne service user was excluded from the imputation analysis as they reported unrealistic resource use (e.g. 200 talking 
therapy appointments) within the first follow-up assessment timeframe. 
cCosts in the standard care group were not imputed. 
 
The total costs to the health and care provider (NHS) before and after imputation are shown in Table 18. They 
comprise the total health and social care services costs, total hospital services costs, total intervention costs and 
total medication costs. In detail, the average total costs for the use of health and care services (before imputation) 
are £591.66 (SD £519.19) for the intervention group compared with £230.88 (SD £378.83) for the standard care 
group. In addition, the average total costs for the use of hospital services are not significantly different between 
the study groups (£37.95 (SD £149.48) in the intervention group versus £5.53 (SD £35.00) in the standard care 
group). The mean total costs of any antidepressant medications are significantly higher (at the 5% significance 
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The costs of Saturday clinics, higher total health and social care services costs and medication costs are likely to 
drive the total costs to the NHS for the intervention group. Pragmatically, the mean total costs to the NHS (before 
imputation) are £895.04 (SD £580.17) for the intervention group and £239.49 (SD £387.34) for the standard care 
group. The patterns remain even after imputing for the missing cost data in the intervention group. Mann-Whitney 
tests show the average total NHS costs to be significantly different (at the 1% significance level) between the study 
groups before and after imputation. 
 






Mean (SD), min-max 
Standard care group 
(n=40) 
Mean (SD), min-max 
p-value (Mann-
Whitney test) 




239.49 (387.34),  
0-1463.89 
<0.001 
Total costs of Saturday clinics 231.13 (129.44), 
51.24-801.95 
n/a n/a 
Total health and social care services costs 





















Mean (SD), min-max 
Standard care group 
(n=40)c 
Mean (SD), min-max 
p-value (Mann-
Whitney test) 







Total costs of Saturday clinics 208.91 (125.48), 
38.05-801.95 
n/a n/a 
Total health and social care services costs 
















SD, standard deviation; n/a, not applicable; Min., minimum; Max., maximum. 
aMedication costs in the intervention group were not imputed. 
bOne service user was excluded as they reported unrealistic resource use (e.g. 200 talking therapy appointments) within the 
first follow-up assessment timeframe. 
cCosts in the standard care group were not imputed. 
 
4.6.3. Sensitivity analyses 
In sensitivity analyses, we considered two other cost scenarios. In the first scenario, we assumed that there is a 
different unit cost for face-to-face and telephone consultations taking place during the week (i.e. a telephone 
consultation costs 40% less than a face-to-face consultation) following limited research evidence on this topic29. 
In the second scenario, we assumed that the practice staff are familiar with the new service, and that the support 
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hour per week and a fixed i-spero fee of £2.50 for each service user. Total NHS costs from the sensitivity analyses 
are very similar to what was presented in the main analysis (see Table 19 for more details). 
 









Cost scenario 1 
Total NHS costs (including cost of Saturday clinics) 
Mean (SD) 871.30 (570.72) 236.69 (387.24) <0.001 
Min. 105.71 0  
Max. 2,697.44 1,463.89  
Cost scenario 2 
Total NHS costs (including cost of Saturday clinics) 
Mean (SD) 887.09 (583.75) 239.49 (387.34) <0.001 
Min. 90.06 0  
Max. 2,731.11 1,463.89  
SD, standard deviation; n/a, not applicable; Min., minimum; Max., maximum. 
 
4.6.4. Additional analysis 
In an additional analysis (Table 20), we accounted for the limited out-of-pocket expenses and loss of earnings 
reported by the service users in each study group to capture the societal perspective. Both loss of earnings and 
out-of-pocket expenses vary substantially from one service user to another, as indicated by the large standard 
deviations. Service users in the intervention group reported significantly higher out-of-pocket expenses (e.g. 
parking tickets, prescription charges) than those in the standard care group, which is not surprising given the more 
frequent use of services and higher medication costs for this group. Total NHS costs remain significantly different 
(at 1% significance level) between the study groups as indicated by the results from the Mann-Whitney test. 
 
Table 20: Additional analysis (out-of-pocket expenses and loss of earnings) 
Costs (£) - societal Intervention group 
(n=44) 




Total loss of earnings 
Mean (SD) 3,143.18 (14,282.24) 728.75 (2,492.91) <0.524 
Min. 0 0  
Max. 88,300 15,000  
Total out-of-pocket expenses 
Mean (SD) 155.61 (698.46) 17.76 (49.51) 0.002 
Min. 0 0  
Max. 4,593 248  
Total NHS costs (including cost of Saturday clinics)a 
Mean (SD) 4,193.84 (14,929.80) 986.00 (2,724.05) <0.001 
Min. 105.71 0  
Max. 93,655.59 16,658.41  
SD, standard deviation; n/a, not applicable; Min., minimum; Max., maximum. 
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4.6.5. Cost-effectiveness 
The intention is not to report results from an in-depth cost-effectiveness analysis. Instead, we will only attempt 
to calculate the ICER by looking further at differences in QoL, and subsequent QALYs between the study groups. 
Given the strict assumption with regards to the QoL of service users in the standard care group at baseline, it 
would be sensible to only present average QoL scores at six months for each group. These are shown in Table 21 
together with estimates of QALYs (after imputation of missing QoL scores). Health-related QoL of service users at 
six months is slightly higher for those in the intervention group than in the standard care group, however, the 
difference is not statistically significant. The picture is similar for the QALYs – service users in the intervention 
group gained 0.007 extra QALYs, which is equivalent to an extra 2.6 days at full health, than those in the standard 
care group. However, the incremental effectiveness (i.e. difference in QALYs between the two groups) remains 
not statistically significant. The attempt to calculate an ICER (i.e. ratio of incremental costs over incremental 
effectiveness) could give an indication of whether the new service is likely to be cost-effective or not. For given 
incremental costs and incremental effectiveness as described above, the ICER in this case would exceed the 
recommended national threshold range (£20k-£30k) making the new service unlikely to be value for money. 
However, we should avoid any further conclusions given the sample size caveats and limited reported resource 
use highlighted in this analysis. 
 






Standard care group 
(n=30)a 
Difference (p-value)b 
QoL score at 6 months 
Mean (SD) 0.628 (0.251) 0.567 (0.245) 0.262 
QALYs 
Mean (SD) 0.303 (0.108) 0.296 (0.062) 0.743 
 
SD, standard deviation. 
aTen service users were excluded from the standard care group sample as they could not be matched to those in the 
intervention group to obtain a QoL score at baseline. 
bDifference: intervention group versus standard care group. Reported p-values are from the t-test of the difference. 
 
Qualitative data provided additional insight into the changes in resources as a result of the intervention as 
outlined by Table 22: 
 
Table 22: Qualitative interview findings on cost-effectiveness 
Component Illustrative quotes 
There was an 
acknowledgment that running 
the clinic was expensive 
largely due to overheads and 
staff costs, especially on a 
Saturday. 
 
“It does increase overheads having to have the building open especially for the 
Saturday clinic where as if we could bring it into the week the surgery is already open, 
we’ve already got staff working so that would massively reduce the costs and then the 
patients would still get the benefit of that service” (KI02T2) 
 
“By having a walk-in clinic on the Saturday morning, that is a cost, an additional cost 
that probably is going to be difficult to justify in terms of the value that you’re going to 
gain from this…My worry is that because of the added resource, rather than just using 
existing resources more effectively, will increase the cost and that will make it be cost 
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“It costs because we have a member of staff or somebody who's working on Saturday, 
which takes them away from the week working because obviously they need that 
time... that's about the only issue in terms of time cost effectiveness that I can see” 
(WS06-07) 
The number of service users 
seen in the clinic was seen as 
sub-optimal which impacted 
on the cost-effectiveness of 
the clinic. 
“We have to look at how we streamline our costs slightly or maximise the patients 
coming through to make it a cost effective service because it is not cost effective at the 
moment” (FG02T1) 
 
“We’re not getting enough patients through, that’s why it’s not cost effective …if 
we’ve got two receptionists, a doctor and then One You counsellor that’s a lot of 
people sat there and especially if You One aren’t being used, then that’s definitely not 
cost effective for them to be sat there all day and not to see any patients… We need to 
get the right balance of the right amount of patients through but also the right 
clinicians available. We need to balance that out. I don’t think it’s more expensive than 
they anticipated I think it’s just the footfall needs to increase” (KI02T1) 
 
The number of service users 
attending the walk-in clinic 
was unpredictable, which 
made balancing staff costs 
difficult. 
“Because it’s a walk in clinic we don’t know if we’re going to get five people in or thirty 
so we could go ahead and get a second GP and only have five people in that day and 
the next week we say no don’t worry and then we’ve got thirty. So it’s just trying to 
sort of juggle the costs that way I think” (KI02T1) 
 
Costs were expected to 
reduce over time as a result of 
reduced appointment times 
once the research had ended 
and the use of technology at 
scale. 
“Obviously it’s a research project so you do have to spend…five to ten minutes 
explaining the whole evaluation side, the consent forms that side of stuff and just 
explaining the whole set up in the first place and then on top of that we are having to 
explain the whole care plan set up and which is another five or ten minutes so 
probably … if you were aiming for twenty minute appointments for severely depressed 
people that wouldn’t be unrealistic for core GMS primary care work actually” (FG02T1)  
 
“So if the technology was spread over a wider population, it would be cheaper because 
the cost per patient would be less. Because a lot of it are just set fixed costs. So the 
more patients you have in it and the wider geography, means that the cost would 
really, really ease out. I think the starting’s quite expensive but, as time goes on, the 
management costs will drop off” (WS01)  
The use of the technology was 
seen as expensive.  
“It is still quite expensive to run and part of the reason it’s expensive to run is because 
the technology is so expensive” (WS01)  
In the longer term, the 
benefits of seeing people with 
mental health needs early and 
by the right clinicians, was 
expected to result in reduced 
treatment costs.  
 
“Somebody who's suffering with low level anxiety and depression is on a waiting list to 
talk to somebody but has got to wait 8 to 10 to 12 weeks to speak to somebody in 
which time their condition worsens, and they end up on medication. So I think there 
absolutely are cost savings and benefits with this model” (WS04-05)  
 
“In terms of long term cost effectiveness, I could see that it would have quite a big 
impact… getting signposted to the correct service to begin with… short term, probably 
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4.7. What could be improved, replicated and sustained? 
Evaluation findings were further organised in Table 23 to extract (1) what improvements were needed to optimise 
the pathway, (2) which key elements then required sustaining long-term to ensure future success of the clinic, and 
(3) which key elements were key to replicate if a similar clinic was established elsewhere.  
 
Table 23: Summary of elements that could be improved, sustained and replicated 
 IMPROVE 
 Element Supporting information/quotes 
1. Widening referral and advertising 
to increase clinic use  
“It would have been a lot busier if they had signposted patients in, so there’s 
probably one or two GPs have done that and the rest have not engaged at all” 
(KI01T1) 
 
“It pulls people in who are possibly at the more severe end and if it was 
renamed ‘wellbeing’, ‘health wellbeing service’ [it]would bring in a broader 
spectrum of patients rather than the severe end (FG01T1) 
2. Implementation into standard 
practice through integrated 
administrative support 
“You kind of need to get that integration between some of our more admin 
functions in the background… I think because the clinic’s being run as like an 
isolated clinic, … we haven’t quite embedded it enough from an admin point 
of view” (KI03T2) 
3. Reduction of waiting times, 
especially with service users 
experiencing anxiety. 
Just over half of intervention group participants (54.4%, n=25) strongly 
agreed or agreed that they did not have to wait long to see a doctor in the 
service experience questionnaire conducted at the six month time point. 
“I was not that impressed because I was… I’d cued up behind one person and 
got to the desk. When I was called the doctors had been the second person, 
the computer hadn’t even been loaded up so then the third person went ahead 
of me. I was… somebody who suffered from anxiety so that, for me, was a big 
thing.” (SU06) 
4. Peer support provision to 
complement services 
“I’m wondering whether or not a peer support group might be beneficial, … so 
kind of having that element of being able to go and meet with other people 
who are also experiencing those kind of difficulties just, you know, just might 
be an additional tool to have within the quiver.” (SU46 at six-month follow-up) 
5. Alternative methods of triage 
outside of the i-spero technology 
to increase accessibility of care 
 
“I did the app out of obligation, because I was asked to by the clinic. I didn’t 
find it helpful in the sense of my journey. I mean I could tell I was anxious I 
didn’t need the app to tell me that, to be honest. I did it as part of, you know, 
participating in the study. But, yeah, it got too onerous after a few weeks” 
(SU23) 
6. Options to improve cost and 
sustainability include: Embedding 
the service into standard GP 
“The only way we continue to make it sustainable…if there's no additional 
funding, is we tweaked the pathway so that they just come into our normal 
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practice weekly hours, consider 
ways to access additional 
integrated services (IAPT and 
OneYou) to remove the need to 
fund these within the primary 
care service, co-location of 
services. These may offset the 
higher costs of running a separate 
Saturday clinic. 
7. Further aligning the service model 
around needs for severe 
depression - assessing essential 
options for relevant treatment of 
this population  
“And they also got me to have some…got me into having some counseling 
quite quickly, which also is very helpful” (SU38) 
 
"I mean there would be weeks when I’d sit there and not have anyone in the 
end, which was right probably because they [the patients] were too severe. 
I’d get a couple, don't’ get me wrong, some people with weight issues and 
then they was signposted correctly but I didn’t think it really warranted me 
sitting there all morning for that really it was a bit of a waste of resources 
and probably money if I’m honest" (KI07T1) 
 
"when people are coming in they’re not necessarily ready for our service so 
the people that are actually coming in are probably more… moderate to 
severe because [...] they’re wanting the meds and they might then be with 
the GP for forty-five minutes [...] and then they’re told oh well we’re going to 
send you through to the One You service and then they’re saying I want to 
go. I don’t want to be here all morning. I want to go. But I think anecdotal 
feedback that we’ve had from the advisor that works here is that a lot of the 
people aren’t actually ready for a behavior change intervention, which is 
essentially what we are about" (FG01T1) 
8. Increasing referral rates from 
other GP practices in the area 
“There is history between the two practices, because they’re run on different 
financial basis, there’s a lot of... it is a very very awkward relationship… one or 
two people have come, I think, from [another medical practice] but whether 
they’re self-referrals or whether they’ve been referred by the GP, I don’t know” 
(WS02) 
 SUSTAIN 
 Element Supporting information/quotes 
1. A structured clinic based on triage 
and integration of services, i-
spero and service user 
involvement 
“[T]he setting that you know it’s a dedicated clinic for those sort of issues is 
really reassuring…” (SU54) 
 
2. Providing options and choice in 
one place or dedicated clinic to 
support improvement in service 
user experience of care 
“I was under the assumption that I was just going to see a GP that day and 
then maybe see a counselor another day and then health and wellbeing, I 
wasn’t, I didn’t realise I was going to see all three in one hit, which was really 
good …” (SU62) 
3. Champions and effective 
leadership to support ongoing 
intervention success 
  
“The GPs have been really engaged. From a management perspective people 
haven’t been up and running with everything from the outset so we’ve had to 
kind of be brilliant at slowly drip feeding the next thing that needs to 
happen” (FG02T1) 
 
“It would be very interesting to see in terms of trying to roll this out say 
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having those champions within the GP setting I think is critical for it to be 
able to work” (WS01) 
4. Team reflection and 
communication with a flexible 
approach to adapt to service user 
need 
“[W]e’ve worked really well together and I think having that feedback from 
us all, we’re quite open and honest with each other, even if we disagree. We 
disagree and discuss and I think that’s brilliant and healthy” (FG02T1) 
5. Timely access to treatment, 
avoiding waiting lists  
“I was able to just go when I felt I needed to as opposed to if you feel you 
need to and then the appointment sometime away whether that’s an hour 
away or a day away or a week away it’s not necessarily getting to you when 
you need it. I think that was important” (SU20)  
6.  Retaining multi-disciplinary skill-
mix 
“Well from one room to another between the three different disciplines if 
that’s the right word […] So I felt that I was getting someone’s complete 
attention who understood the nuances of my condition and had the time to 
think about it if you know what I mean. I think that worked” (SU20)  
 REPLICATE 
 Element Supporting information/quotes 
1. Professionals based in primary 
care with a special interest in 
mental health and advanced skills 
as a result 
“We’ve got lots of clinicians, patients generally see a different clinician every 
time and quite often generally mental health isn’t the interest of many 
clinicians … myself and [name] have got a lot of interest in it so you get more 
empathy” (KI08T2)  
2. Taking time with service users to 
provide holistic care 
“It’s amazing that you can just turn up and get to see really skilled doctor 
who is willing to give you the time to talk through things” (SU03 at six-month 
follow-up) 
3. IT support would be required both 
from practices to support services 
users in use of the i-spero tool but 
also from the i-spero team to 
support practice implementation 
 
“I really do like the technology, I find it really helpful to use alongside 
speaking to people, I think generally people feel, I think they really like it, I 
think they like monitoring themselves as well, it’s a positive thing” (KI01T1)  
 
“We provided a live help desk availability … so I think that really helped 
provide confidence for everybody in terms of making sure that the software 
did work… because of that live support that was provided right at the 
beginning... ” (WS10) 
4. Symptom tracking was seen as key 
to service user improvement  
 
“I think it was really useful having that element of being able to self-monitor 
by using the PHQ-9 and GAD-7 and kind of having it in a place where you 
could see progress or deterioration, dependent on week-by-week basis. But 
also the fact that it was quite reassuring, reaffirming or […] identifying that 
you might need to go to the clinic to look at a change to treatment. So I think 
it was really user-friendly and it was a really good therapeutic tool in itself, 











The new service was effective in its primary aim of improving mental health support for those experiencing low 
mood, anxiety and depression in a GP practice setting. This was evidenced in those receiving the intervention by 
a reduction in depression symptoms (symptoms of depression, anxiety and suicidal ideation) and improvement in 
service user sense of wellness. The reduction in depressive symptoms and suicidal ideation was reflected when 
comparisons were made with standard care, however, differences between groups were not observed for anxiety 
symptoms or a sense of wellness. A particular strength of this study is the ‘real world’ observation and assessment 
of service user outcomes and implementation10-11. The difficulties involved with implementing a new multi-
disciplinary care model with combined digital technology were complex.  Therefore, allowing for rapid feedback 
from the evaluation, flexibility and a dynamic intervention that could be updated to ensure it was fit for purpose 
and responsive to service users was critical. 
 
The positive effects of the use of digital applications for the management and care of those with common mental 
health disorders are well documented12, 40. The technology used to support the multi-disciplinary clinic, i-spero, 
was reported as easy to use and beneficial because it enabled service users to record and track their progress 
over time.  Practitioners also found i-spero particularly useful in guiding triage and clinical management; however, 
it may not be suitable for everyone, due to the nature of their condition, age, digital skills  or other factors. Access 
to alternative forms of symptom assessment (such as paper copies, free to access online surveys using tablets or 
practitioner-led symptom assessment) would improve accessibility for those unwilling or unable to use the 
technology and increase service user choice. Key features critical to the technology as observed by service users 
and practitioners included ease of use, the ability to rate mood/anxiety levels on a scale and the option to 
personalise the app in particular for practitioners recording care plans (which has been reflected in other 
studies41). Elements identified as required for service user engagement of i-spero and in other studies42 include: 
understanding the purpose of the assessments (in particular the PReDicT test), the practitioner’s role in 
reinforcing and supporting app use (although this added to workload) and reduction in burden of the system 
created by service user deterioration or suicide alerts. Many individual studies have shown improvement in 
common mental health disorder symptoms with digital technology use.  However, critical to the success of any 
digital technology for symptom monitoring and care is engagement and regular use which has been shown to be 
linked with symptom improvement in many cases42-46.  
 
Service user improvement was due to the holistic approach with ‘joined up’ and co-ordinated care from multiple 
service providers. Holistic care was enabled by the integration of the clinic with other supporting therapy services, 
the technology and service user involvement. The service also served to meet the needs of the local population 
and potentially the rise in mental health need as a result of COVID-19. The care model critically led to better 
integration and co-ordination between primary care, other NHS services from other providers and other social 
and voluntary care sector services. Embedding these additional services in primary care may have enabled 
improved access and willingness to engage in these types of therapy. Critcally, to enable scale and spread, an 
integrated service should be designed within emerging integrated structures such as primary care networks and 
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There was a high level of service user satisfaction, due to the quality of care received from individual practitioners 
and the timely single point of access to assessment and multiple services, specific to their needs (i.e. better 
patient-centred care). A key factor in the success of the clinic was the multidisciplinary team approach involving 
practitioners who had a special interest and skills in mental health and wellbeing. Therefore, increasing and 
embedding GPs with special interest roles or other mental health specialists within primary care may support care 
for common mental health discorders47. Practitioners also believed the service enabled users to recover more 
quickly as service users were able to monitor their progress and take part in shared decision-making (self-
management). Of significance here was the regular use of service user-reported outcome measurements 
(PROMs), in this case PHQ-9 and GAD7, to inform clinical management and treatment. Indeed, regular use of 
PROMS alone may be sufficient to increase quality of care for depression in a primary care and community setting6-
7,9.  
 
There is a higher level of depression in the locality than the national average (16.5% within the locality compared 
to 11.6% nationally), signifying that the service had identified and was responding to a local need or gap in service 
provision. Service users, overall, had more severe symptoms of depression and anxiety than anticipated when 
designing the new service pathway. This was felt to be due to a lack of capacity of mental health services locally, 
mirroring the national picture48. The severity of presentation symptoms for depression and anxiety led to the need 
to change and adapt the pathway to meet the needs of the population. As in many new service initiatives, having 
champions and effective leadership was instrumental to success49. An over-reliance on a small number of key 
individuals makes the service vulnerable to staff change.  
 
The higher costs of the intervention are reflective of an enhanced service, running outside of usual clinic hours by 
multiple agencies. The nature of the clinic as a ‘walk-in’ service also makes it difficult to accurately anticipate 
demand and, therefore, staffing (with associated costs). It is likely that costs could be reduced by integrating the 
clinic, service user follow up and administrative support within usual weekday provision and/or increasing the 
number of service users49. Embedding the service into standard GP practice hours would also improve 
sustainability of staffing in the longer term. Consideration of ways to access additional integrated services (IAPT 
and OneYou) within their usual business hours would remove the need to fund these additional IAPT and OneYou 
services within the primary care service, for example, co-location of services. The cost of the technology might be 
reduced by its use across a wider geographical footprint (more Primary Care Networks). It is hypothesised that 
cost benefits might occur in the longer term by reducing the need for secondary mental health care and improving 
the prevention of suicide through proactive service user symptom monitoring and the i-spero suicidality alert 
system.  
 
COVID-19 was a significant contextual factor influencing both the mode of service delivery and the number of 
service users being referred to the service. Despite recruitment to the evaluation having been completed before 
COVID-19 lockdown, the situation may have affected symptom reporting of those still in the follow up period 
reducing the changes in symptoms detected. 
 
Going forward, there is a need to continue to seek innovative ways to increase referral/self-referral rates and 
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support between service users was also suggested as a way to enhance the service further. Most importantly, 




Limitations to this evaluation included a lack of ethnic diversity in the sample groups as reflected by the local 
population characteristics. A lack of quantitative patient-reported outcome measures being collected within 
standard care practice left limited options for comparative data collection and analysis with the intervention. 
Recruitment fell short of optimum sample size for the standard care group. Furthermore, the combination of novel 
technology and a newly designed service limited the ability to attribute changes in service user outcomes in 
particular to these separate elements of the intervention. As the evaluation was conducted at a single GP practice 
this created limited practitioner involvement in the delivery of the intervention and care provision which may 
have decreased the variation in outcomes and experiences in continuity of care compared to a study involving 
more delivery sites. Although the study evidenced improvement in service user outcomes, the variability of service 
provision across primary care means that transfer of the intervention as designed to other localities is unlikely, 
however, replicable elements were identified that could be taken up by other primary and community services. 
Finally, the context of COVID-19, although not impacting on evaluation recruitment, may have affected changes 




The new service was effective in improving mental health support for those experiencing low mood, anxiety and 
depression in a GP practice setting as evidenced by a reduction in depression symptoms compared to standard 
care, and the personal perceptions of benefits as highlighted by participants. The technology used to support the 
multi-disciplinary clinic, i-spero, was easy to use and beneficial, enabling service users to record and track their 
progress over time; a feature that also enabled practitioners to guide triage, treatment and clinical management. 
Service user improvement was due to the holistic approach with ‘joined up’ and co-ordinated care from multiple 
specialist service providers in a timely single point of access. The intervention was more costly than standard care, 
however, this was reflective of the enhanced service, running outside of usual clinic hours by multiple agencies. 
Costs could be reduced by integrating the clinic, service user follow up and administrative support into normal 
business hours (weekday provision) and/or increasing the number of service users or geographical footprint. It is 
hypothesised that cost benefits might occur in the longer term through reduction in need for secondary mental 
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Appendix 2: Key changes to the intervention during implementation 
 
Table 5 below details changes made to the intervention over the duration of the evaluation recruitment and follow up period (6th July 2019 to 30th June 2020). 
Changes to clinical pathway 
Change made Reason Date of 
change 
Wi-Fi boosters purchased for the clinic Connectivity-related drop-outs and log-outs were reported by service users and staff; 
in case of poor Wi-Fi, the PReDICT test was reported to ‘loop’ 
September 
2019 
Clinic rebranded as more of a ‘wellness’ clinic and 
not simply for depression 




A new leaflet that better-explaining the different 
parts of the clinic provided, including summary 
information of One You and IAPT service users 
available outside the lcinic 
Designed because service users reported lack of clarity on what to expect from 
different part of the clinic before the appointments. Clinic staff also reported not 
knowing the full remit of IAPT and One You services  
November 
2019 
Additional support provided at the end of 
consultations by practice receptionists for i-spero 
use 
To increase use of care plan functionality, receptionist supported service users to 
input care plans at the end of the consultations at the clinic 
November 
2019 
Some clinic follow-ups carried out by the GP during 
the week. 
Rising numbers of walk-ins and repeat follow-ups resulted in level of demand hard to 




Change in the order of healthcare professional 
seeing service users.  Wellness support moved to 
first appointment to be conducted which triage 
happening 
In order to reduce waiting times and increase use of wellness services  November 
2019 
Order of services returned to at start of intervention. 
Returned to triage and GP consultation first 
Wellness services were not appropriately skilled to see severe service users without 
first consultation with GP after triage. 
January 2020 
Second GP working at the clinic added To reduce waiting times and cover increased follow up appointments a second GP was 
recruited to work within the clinic team 
January 2020 
Nurse practitioner working at the clinic To reduce waiting times and added pressures resulting from COVID-19 March 2020 
COVID-19 adaptation to online consultation only COVID-19 resulted in service users being asked not to attend in person to reduce risk 
of COVID-19 transmission 
March 2020 
Changes to i-spero technology 
Change made Reason Date of 
change 
Software changes on recommendations by the 
Patient and public involvement group. 
Multiple functionality changes to ensure usability June 2019 
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There were other aspects that clinic staff commented on as needing improvement, but ones that were either outside of their control or could not be addressed 
during the evaluation period. 
 
There were: 
 Information sharing issues, which meant that triage notes would not always appear on the EMIS system in time for clinic staff to see the notes from 
the previous clinician whom the service user saw on the day 
 Some staff reporting a small number of service users coming back each week for a number of consecutive weeks and were not sure how to address 
this 
 Record keeping was reported to take up an unexpected amount of time, affecting time that could be spent seeing service users 
Software release 1.1 Production launch of i-spero for the Kent CCG July 2019 
Software release 1.2 Multiple features and change requests including: 
 Fix for bug where patients missing off the “All GP Practices” but appearing 
on “GP Practice 1”. 
 OPT-D Participant ID field added  
 GP Practice Dashboard Patient List view - Search by full last Name feature 
(e.g. Smith not Smi). 
 Personal details - DOB Age range 18-70 has been changed to 18+. 
 Results tab Graph on Dashboard - Hover over link on plot point is larger so 
more usable.  
September 
2019 
Software release 1.3 OPT-D Study Dataset reports added August 2019 
Changes to alerts – overly risk averse alerts Alert parameters for symptom deterioration amended so that they are only triggered 
for moderate or severe service users to reduce GP practice burden 
Sept 2019 
Access to i-spero for wider practice GP team Enable named GPs not involved in the clinic to view i-spero assessment and provide 
continuity of care for service users returning to normal hours appointments 
Sept/Oct 
2019 
Software release 1.4  Enabling Care Plans to be added/editable by GPs (highest priority issue identified by 
Kent CCG) without requiring the patient to log on themselves.  Log-in issues resulted 




i-spero central tech support ceased Discussion between lead practice and P1vital Ltd resulted in agreement to remove 
central tech support provided by P1vital Ltd 
Feb 2020 
i-spero central tech support reinstated Need for additional central tech support as users were experiencing difficulties 
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Appendix 5: Unit costs used in the health economic analysis 
 
Appendix 5.1: Unit costs of running the Saturday clinics 
Item Unit cost (£) Duration Source 
Reception 20.74 per hour 9 hours per weeka Newton Place Surgery 
Management 28.35 per hour 4 hours per weeka,b Newton Place Surgery 
GP1 439.95 per session 1 session per weeka,c Newton Place Surgery 
GP2 109.98 per hour 2 hours per weeka,b Newton Place Surgery 
Nurse 34.37 per hour 4 hours per weeka,b Newton Place Surgery 
IAPT 130 per week n/a Newton Place Surgery 
OneYou 446.75 per month n/a Newton Place Surgery 
Additional (monthly) costs associated with 
Reception (overtime) 20.74 per hour 10 hours per montha Newton Place Surgery 
Management 40.10 per hour 24 hours per month Newton Place Surgery 
Management admin 18.90 per hour 40 hours per month Newton Place Surgery 
GP sessions 439.95 per session 4 sessions per monthc Newton Place Surgery 
n/a, not applicable. aon average bManagement, GP2 and nurse were not present in all Saturdays. cEach session is equivalent to 4.25 hours per week. 
 
 
Appendix 5.2: Service user-reported health and social care use and associated unit costs 
Item Unit cost (£)a Source 
GP services   
GP 39 Personal Social Services Research Unit (2019), pp. 120, per 
surgery consultation lasting 9.22 minutes (including direct 
care staff costs and qualifications)b 
Nurse practitioner 42 Personal Social Services Research Unit (2019), pp. 118, per 
hour (including qualifications) 
Mental health 
worker/nurse 
55 Personal Social Services Research Unit (2019), pp. 117, 
Band 7, per hour 
OneYou 39c North and West Kent OneYou, per appointment 
Community-based services   
Community mental health 
centre 
55 Personal Social Services Research Unit (2019), pp. 117, 
Band 7, per hour 
Group therapy or talking 
therapy 
55 Personal Social Services Research Unit (2019), pp. 153, 
Counsellor Band 7, per hour 
Dietitian 56 Personal Social Services Research Unit (2019), pp. 143, 
Band 7, per hour 
Social care services   
Occupational therapist 48 Personal Social Services Research Unit (2019), pp. 133, per 
hour (including training costs) 
Service user support or 
self-help groups 
25 Personal Social Services Research Unit (2019), pp. 136, per 
hour 
Hospital services   
Acute psychiatric ward 226 National Schedule of Reference Costs 2018-19, Mental 




217 National Schedule of Reference Costs 2018-19, Mental 
health, Code: MHST, per care contact 
Psychiatrist 46 National Schedule of Reference Costs 2018-19, Total 
outpatient attendance, Code: 722, per appointment 
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Occupational therapist 70 National Schedule of Reference Costs 2018-19, Total 
outpatient attendance, Code: 651, per appointment 
aAll unit costs, except where specified, were adjusted to 2020 prices using the CCEMG-EPPI Centre Cost Converter (https://eppi.ioe.ac.uk/costconversion/default.aspx). 
bNo separate unit cost was provided for telephone consultations per se. 
cProvided in 2020 prices. 
 
Appendix 5.3: Medication use and associated unit costs 
Item Dose Unit cost (£)a Source 
Citalopram 5mg 0.22 eMIT 2019, code: n/a, package of 28 
Citalopram 10mg 0.26 eMIT 2019, code: DDC129, package of 28 
Citalopram 20mg 0.31 eMIT 2019, code: DDC135, package of 28 
Citalopram 30mg 0.50 eMIT 2019, code: n/a, package of 28 
Citalopram 40mg 0.69 eMIT 2019, code: DDC130, package of 28 
Duloxetine 30mg 1.61 eMIT 2019, code: DDC189, package of 28 
Escitalopram 5mg 0.43 eMIT 2019, code: DDC158, package of 28 
Escitalopram 10mg 0.59 eMIT 2019, code: DDC156, package of 28 
Escitalopram 15mg 1.04 eMIT 2019, code: n/a, package of 28 
Escitalopram 20mg 1.28 eMIT 2019, code: DDC157, package of 28 
Fluoxetine 20mg 0.25 eMIT 2019, code: DDI014, package of 30 
Fluoxetine 60mg 0.80 eMIT 2019, code: n/a, package of 30 
Mirtazapine 15mg 0.46 eMIT 2019, code: DDC177, package of 28 
Mirtazapine 30mg 0.64 eMIT 2019, code: DDC080, package of 28 
Mirtazapine 45mg 0.77 eMIT 2019, code: DDC178, package of 28 
Paroxetine 30mg 1.08 eMIT 2019, code: DDI013, package of 30 
Pregabalin 150mg 2.69 eMIT 2019, code: DDH134, package of 56 
Quetiapine 50mg 3.25 eMIT 2019, code: n/a, package of 60 
Quetiapine 75mg 3.32 eMIT 2019, code: n/a, package of 60 
Quetiapine 150mg 3.39 eMIT 2019, code: DDB181, package of 60 
Sertraline 50mg 0.66 eMIT 2019, code: n/a, package of 28 
Sertraline 100mg 0.79 eMIT 2019, code: DDC041, package of 28 
Sertraline 150mg 0.95 eMIT 2019, code: n/a, package of 28 
Sertraline 200mg 1.60 eMIT 2019, code: n/a, package of 28 
Venlafaxine 37.5mg 0.90 eMIT 2019, code: DDI015, package of 56 
Venlafaxine 75mg 1.79 eMIT 2019, code: DDI016, package of 56 
Venlafaxine 150mg 1.80 eMIT 2019, code: DDC068, package of 28 
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Appendix 6: Recommendations for improving i-spero and usefulness of features 
 
Interviewees were asked to comment on the features they found most useful features of the app, as well on whether any changes or additional 
functionality was desired. Due to the fact that the way service users and staff interacted with i-spero, feedback below is separated into service 
user, staff and wider informant groups.  
Service User recommendations 
The most common suggestion (by far) 
was being able to add comments next 
to GAD-7 and PHQ-9 scores to 





One service user also suggested that 
inputting contextual information may 
help identify triggers for dips in mood 
“I still think it would be nice to just have a section on it where you can write notes. [W]hen you’re monitoring it would be really 
useful to know actually that was because that happened this week or because I knew I had that coming up or, you know, what 
ever it is I just think that’s quite helpful” (SU3 at six-month follow-up) 
 
“Put a reason in for…a specific…event or something that may have caused an up or down because at the time it wouldn’t matter 
but if you were looking back it would give you a reason as to oh yeah I was bad that week but this is why. Because later on you 
probably wouldn’t remember why without looking in there…” (SU05) 
 
 
“[T]here’s no flexibility is there, it’s just the questionnaires, there’s no... You can’t input a paragraph or explanation. It might be 
good for people with other, like eating disorders and things like that so there’s a trigger, they might start recognising the 
triggers of why...” (SU66) 
 
Listing medication that is taken at 
different intervals than currently 
offered 
“I had another medication that I wanted to list on it and it basically a and it’s like a migraine prevention injection that I  have 
once a month but because of the type of medication there wasn't’ really an option for it so because I think it only had 
suggestions for like once daily or like twice daily but I only take it once a month […] I ended up putting once daily and then wrote 
a note saying this is once a month or something” (SU01) 
 
Ability to change medication records 
easily 
“I’ve had change of medication and bits like that…it’s not always been intuitive to me. I’ve got there but it’s not been intu itive 
and…other than that I think it’s pretty good actually” (SU20 at six-month follow-up) 
Shorter or more varied Predict test 
content 
 
“I think the face recognition one was really lengthy and I think when I first did it and I was kind of feeling really low that was the 
only one that just felt a little bit overwhelming” (SU03) 
 
“[T]he part that did drive me nuts was seeing all those faces again and again and again. Is it happy, is it sad, is it…this that and 
the other. That was quite infuriating, to be honest with you […]  I get the science behind it that you’re making a snap judgment 
on reading emotions I do get that but it was…it was nicer to see maybe a few different faces or something” (SU06)  
 
Different assessments to PHQ-9 and 
GAD-7 (both in terms of the questions 
and in terms of response options) 
 
“I don’t know if it can be tailored in any way to specific scenarios because I did feel that all though I was answering the 
questions I almost feel like I was lying because the way the question was worded wasn’t sort of particularly relevant to my 
situation […] I just think maybe carers, people who are full time carers fall into a slightly different category?  I’m trying to do this 
this and this, you know, and I suppose in one way that’s anxiety because I haven’t got the time to do it and feeling overwhe lmed 
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“[I]f there was more options in terms of responses, maybe that could prove more helpful to the individual and to the service”  
(SU44) 
 
Different assessments to PHQ-9 and 
GAD-7 (both in terms of the questions 
and in terms of response options) 
 
“I don’t know if it can be tailored in any way to specific scenarios because I did feel that all though I was answering the 
questions I almost feel like I was lying because the way the question was worded wasn’t sort of particularly relevant to my 
situation […] I just think maybe carers, people who are full time carers fall into a slightly different category?  I’m trying  to do this 
this and this, you know, and I suppose in one way that’s anxiety because I haven’t got the time to do it and feeling overwhelmed 
all the time” (SU16) 
 
“[I]f there was more options in terms of responses, maybe that could prove more helpful to the individual and to the service”  
(SU44) 
 
Clearer benchmarks for PHQ-9 and 
GAD-7 scores and ability to look up past 
scores on specific items 
“And there’s lots of data that you can see about yourself, obviously the time it takes to react and so forth but there’s noth ing to 
say whether that is within normal range. Whether that’s below normal, you know, there’s no kind of understanding of what that 
predict test is doing” (SU04) 
 
“[T]here was no way to look back at previous answers, I don’t know if this is a thing that was done on purpose or not but I found 
that I wouldn’t remember whether I’d scored a certain thing a 6 or a 7 and in some ways you’re kind of making your own 
boundaries for what a 6 is and what a 7 is or whatever it might be, so sometimes you think well, I am feeling better than last 
week but I don’t remember whether I put 6 last week or a 7 and so I don’t want to, you know, give the wrong information” 
(SU59) 
 
More sensitive suicidality assessment 
questions, differentiating between 
suicidal feelings and suicidal intent 
“[S]o there’s a question which asks something along the lines of, you know, do you feel like it would be better if you weren’t 
here, or if you were dead, or something like that, and my answer to that on a number of occasions triggered a phone call from 
the GP, which is fine, but I felt a bit guilty that you know, they were taking up their time, and I guess the only thing would be as 
sort of a differentiation between that question and sort of another one being ‘do you have any intention to harm or kill yourself’ 
[…] probably could save the doctors some time as well if it was made a bit more explicit” (SU33) 
 
“Sometimes it is very hard to judge how to answer that […] especially that thing of things like have you thought you’d be better 
off dead or…you know, have you thought of suicidal…well when I was suicidal that was very clear cut. I don’t know if that 
means…if I think I would rather not be alive now does that cover” (SU36) 
 
An app instead of a website link 
 
“There’s just an online link so for me actually having an app on the phone that would be a better option” (SU06)  
 
“So, rather than being a desktop-based or web browser-based programme, to have something specific for iPhones and Android 
users that could then set up notifications that come through onto your front screen” (SU17 at 6-month follow-up) 
 
Ability to choose the most convenient 
time to receive reminders 
 
“It would be really good if you could choose what time of the day you got sent the reminder emails because they just come 
through at half eight in the morning but at that time I’ve already been at work for three quarters of an hour so if I’ve forgotten 
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to take my tablets it’s too late. So I would like to be able to choose what time I get that email through in the morning because 
it’s very useful to have the reminder…but, yeah like I say it would be good if you could choose what time you got it” (SU04) 
 
Ability to set and track personal goals 
on the app 
 
“[I]t would be really interesting to…again they can show it like a graph like on the depression and anxiety and day-to-day tasks if 
they could show some kind of a graph or something like that that interprets all those results a little bit more it would be good to 
see as well” (SU04) 
 
“[S]ome sort of habit tracker where you can put various different tasks that you want to do during the day being able to tick  
them off” (SU17) 
 
“[W]e say fitness helps us, we say it’s good for the mind, if we was tracking that and tracking our minds at the same time maybe 
we would see a crossover and then maybe it might click into people’s heads “do you know what, you felt better last week - but 
that’s because you went out every day and you ran the school field or that’s because you didn’t start eating all that crap out of 
the cupboard” (SU46) 
 
Information on how to access other 
services 
 
“Perhaps links to the other services […] Like the counseling service and the community service, have links to what they do as well 
within the application. And it kind of…if you look at it as a hub for treatment of which medication and targets and reducing 
alcohol of that’s a problem or whatever all parts of that as well as your weekly reviews, you know, having used additional 
support from there, it might be useful for some” (SU20) 
 
Ability to seek professional advice via 
the app 
 
“I suppose the only thing you could ask is maybe to submit some questions that could be put to practitioners that use the service 
about advice and what their thoughts are on it. So I’ve had some sort of general questions of whether I should switch the time of 
day I take my medication and stuff like that so yes if you could pose a question that could be picked up by one of the GPs or 
therapists and their advice, might be useful” (SU54) 
 
Ability to share app assessment scores 
with other providers (e.g. counselling) 
“[E]very time I went to see [the counselor] there were almost identical sheets that you had to fill out at the start of every time 
[…]  I’ve got no problem if that information was passed around” (SU44) 
 
Signposting/information on arranging 
repeat prescriptions 
“I think it would be great on there if you could generate something through the portal that says, I need to re-order my next 
repeat prescription instead of me walking down to Boots” (SU70) 
Generating alerts not only when scores 
drop, but also when they stay the same 
(i.e. someone remains clinically 
depressed based on the scores without 
a deterioration) 
“I suspect just to come up with the if your flat on medication and your scores haven’t come down it’s probably a good idea to  go 
to the clinic or whatever. It seems to only prompt that when there’s been a change in medication” (SU20) 
 
Text alert or push-notification option 
 
“I know it sends you emails but text alerts would also be quite useful” (SU11) 
 
“[T]here should be some sort of an alarm or something sort of like that goes “come on, you’ve not done this today” (SU65)  
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Issues with log-in were also reported by 
a group of service users: 
 
“[O]n my tablet that I use it occasionally, I try to log in, it tries to sign me in as a new user rather than logging me in as the user I 
am but if I refresh it logs me in properly if that makes sense. So I’ve have that glitch a few times but other than that no other 
glitches” (SU04) 
 
“I’ve had some problems logging on, quite a few problems actually. So I was supposed to be doing some, um, the questionnaires  
and things but I was thrown out quite a few times, so I contacted someone and then it took a bit time for them to get back to 
me, and then I’ve got to re get on again now and do another questionnaire. So I’ve had a few, well quite a few technical issues 
with it actually […]so it’s quite difficult because I obviously want to do the questionnaires but I can’t do that. So I haven’t really 
had the time to sort of chase it up as such to get it sorted out” (SU41 at 6-month follow-up) 
 
“They’d been trying to sort my, the online thing that we have, they tried to sort my password login thing, so I spoke to them 
probably about, I don’t know, about six weeks ago just to re-do my login” (SU47 at 6-month follow-up) 
 
One service user remarked that it 
would have been useful for clinic staff 
to be able to reset passwords when 
needed: 
“Even now remembering stuff is difficult for me so passwords are quite hard… [Clinic staff] couldn’t affect it or edit it which I 
think in some ways would have been a useful for them to be able to do to help me” (SU20) 
 
Clinic staff recommendations 
Providing a clearer, detailed 
explanation behind the Predict test and 
information on how to use it 
“One of the issues is with the faces test…and I think that probably could be solved with just explaining to people before they 
start, putting some kind of caveat around it so to say there’s no right or wrong, to say it’s fine if you miss one it doesn’t matter, 
you know, see what the next one is. And there are lots of faces so it’s looks like your overall perception so getting one wrong 
doesn’t matter or getting ten wrong doesn’t matter that’s why there are so many of them” (KI01T2)  
Consenting to taking part in research to 
be built into the app 
“Can the research statement be part of the app? The faces test needed more information – what is was about and how to 
complete it, more video animations, reminders via text rather than email for users, improving the patient search function for 
GPs, only runs on particular versions of iOS. Having a statement on the app would be a better way of filtering out if someone 
doesn’t actually agree with it… whether they could be booked in maybe in the week with time to see a GP” (FG01T1) 
Ability to flag up if care plans are not 
set in the original meeting with the 
service user and to do so remotely  
“If some of my other colleagues who haven’t set them up with [service users], their care plans haven’t been done which means 
the tests don’t then flag because there’s no entry of any medication being initiated. So they can’t follow the protocol” (KI01T2) 
Wider informant recommendations 
Introductory information, such as a 
video, on how to use the app and its 
functionality (this has largely been 
implemented already) 
 
“I think there’s more self-help that we could provide within the application itself to sort of, to if you like prompt and provide tips 
and hints of how to use the technology so that patients who are doing it on their own from home they have a little bit more, if 
you like they have someone, a virtual someone providing them some guidance and what to do and why they’re doing what 
they’re doing, to try and get them more engaged in what they’re actually doing […]  We put more sort of video animations in, so 
we actually got some little videos which you can play which gives you a little bit more context, a little bit more understanding of 
what this i-spero app is, why you’re using it. So I think there’s more things we can do with what I would call the engagement 
education piece, which we’re starting to look at now to try and make it easier to learn how to use the technology and get the  
most out of it” (WS01)  
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Providing text alerts instead of email 
alerts 
 
“I think the other weakness is because we communicate reminders through email, we’ve already been looking at most recently 
also about texting because I think some people would probably rather receive a message by text than they would by email 
because they may not check their email very regularly…I think looking at other ways of providing that connectivity to a user and 
making it more personalised to what their needs are would be an advantage… So I think it’s about engagement, it’s about 
access and engagement I think are the two areas that I’d like to look to see if we could improve upon in terms of the 
application” (WS01) 
Service user ability to choose when the 
alerts are provided 
 
“Making it more personalisable by the patient I think would be another component, so that they, for example “I’d like to get my 
reminders at 8 o’clock in the morning” or “I’d like to get my reminders at 8pm in the evening”, “I like to get them by text or by 
email”, so they can choose, so each patient can choose what’s best for them. Or they can say “I don’t want any reminders”, you  
know or, so I think making it a little bit more flexible that way would be good” (WS01) 
Allowing for a more diverse set of 
alerts, tailored to service user needs 
“There was a lot more alerts that [name] and I discussed and we decided not to implement some of them but actually I think 
some of them would have been valuable” (WS01) 
Enabling clinic staff to find service user 
records on i-spero in an easier, quicker 
way 
“One other change I’m just thinking about, that we should do that we haven’t done is relating to being able to find patients 
more easily and more quickly” (WS01)  
Before i-spero becomes an app, 
ensuring that it can run on a wider 
range of operating systems 






As well as making recommendations, respondents identified a number of features they found helpful. By far the most commonly mentioned useful 
feature among the service users was symptom tracking, which introduced the ability to see scores and symptom progression overtime: 
 
“It was useful because it just helped to monitor how you feel and like I said before sometimes you don’t necessarily recognise yourself that there has been 
an improvement in how you’re feeling”(SU03) 
  
I think it’s actually just seeing the graph at the end of it to know, because you might think, ‘oh yes it’s been an alright week, same as last week’, but 
actually when you look back your line’s moved up or down and think you think, ‘oh okay’, it kind of makes you reflect on it as to what actually has 
happened. (SU69 at 6-month follow-up) 
 
Service users emphasised the importance of the felt change in symptoms being backed up by scores and graphs on the i-Spero app, reassuring the 
users that the change was – in their words – a ‘real’ one.  This was useful both as reassurance to the service user themselves, and in communicating 
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“I’m a lot less depressed than I was, which is letting me get on with my day-to-day life. I’m back at work […] it was a beautiful confirmation because 
about four or five days before I did the predict test I started to feel a lot lot better and then I did the predict test and it said that I’m now responding to the 
medication and it was a lovely sort of confirmation of what I felt about myself.” (IDC04) 
 
“That’s been great, because I feel like the normal approach when you go to the doctor is they’re like, “How are things?” and it’s like, “Not great,” and 
maybe we could go out kind of the same as you came in, or maybe something’s just, you know, a dosage has been increased or whatever slightly, but this 
has been, it has felt like a more quantitative approach to it, because I’m like, I’m actually not feeling great, and look, this is how my questionnaire kind of 
indicates, it’s not just based on what I’m saying in a kind of, a short consultation, it’s also got that behind it as well” (SU33) 
 
Service users also remarked on using symptom assessment questions as a platform for self-management (specifically concentrating on areas where 
the scores were lowest): 
 
“I think it was really useful for me to be able to reflect on how I was doing and to monitor that myself and to kind of take a bit of ownership of it really. 
And to see actually I can see that I’m moving forward with things and things are feeling better. And also I think what’s really useful was in with the 
questions because as I do kind of like to reflect on things you could kind of see right ok what is it that I really need to work on?” (SU03) 
 
“[S]o I'm also a numbers person. So actually both of those things lend me to trend analysis I guess so I’ve turned that in and on myself to see am I getting 
any better, am I not? It’s also helped me to characterise how I’m feeling both in myself but also in conversation with my family. And I’m going to use that 
for that purpose. I think for me that is the most beneficial part of it because a) I can start to reassure myself that I’m feeling a bit better when I am or if 
I’ve had a bad week, I’ve had a bad week and I can see either it’s a spike or a it’s a trend and therefore address it accordingly” (SU20 at 6-month follow-
up) 
 
“[S]eeing where I’ve sort of, I know I’ve sort of noticed a bit of a pattern, because I’ve got problems with my periods as well, so I’ve noticed a bit of a 
pattern with that as well. Because my mood drops, I’m having, I’m under the doctors for that at the moment as well, like my periods and stuff” (SU28) 
 
The ability to evaluate via i-spero whether the service users responded well to medication has also been mentioned by many as a useful feature: 
 
“It’s just been really useful to see how effective or not effective the medication is and the predictor test has kind of indicated to her that she needs to 
increase the medication or change the medication and she said that kind of it’s quite useful to do that and it means that I’ve kind of got onto a better 
medication perhaps more quickly then I would have done in other circumstances like without the test results” (SU03 at 6-month follow-up) 
 
“I think we actually changed type again and then became that kind of indicated that things had improved but not really significantly then the doctor kind 
of played around with the dosage a little bit. And again that was, it was helpful because I didn’t have to wait, you know, six weeks and then go back and 
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However, one respondent spoke about the Predict test suggesting a change in medication despite an improvement in symptoms on PHQ-9 and 
GAD-7, and the resulting confusion: 
 
“I was doing the sort of weekly questionnaire to kind of monitor my progress. And so it was, I mean the software was sort of saying that I would be better 
off on another medication. Which was kind of, I thought that was a little bit strange because according to the chart I was starting to improve” (SU01) 
 
While this was mentioned fewer times than the usefulness of symptom tracking, many service users commented on the importance of app 
integration within the clinic and ability for GPs to remotely monitor scores: 
 
“I think if the app wasn’t linked to the doctor it probably wouldn’t have got my attention to start with. Because if I felt that nobody else was looking at it 
then it would be one of them things that I’d maybe do a couple of times and then nobody checked in, nobody asked any questions and I just didn’t do it 
again” (SU47) 
 
“I guess alone it’s very similar to other mood trackers, but as an app that’s linked into your GP and like your actual medical care I would recommend it to 
others, if their surgery was running, you know, a service where their GPs were able to look at this and use it then I would definitely recommend it” (SU33) 
 
“I think it’s really important and I love the fact that Dr. [name] can see how I’m doing because she’ll ring me up and like the last time she rang me up 
because she can’t see [my scores]” (SU36) 
  
Some service users stressed that the app enabled the GP to get in touch with them sooner than they would have otherwise reached out for 
support, ensuring prompt treatment and preventing avoidable deterioration: 
 
“I unfortunately had a relapse back in December and Dr. [name] at the clinic instantly spotted my scores. I went in that next weekend and she was 
expecting me because she knew my scores had gone down from looking through the app and she was just absolutely fantastic” (SU04 at 6-month follow-
up) 
 
Medication and other reminders were useful to many service users, too: 
 
“I’ve found the system an excellent reminder. Very kind, you know, the points like alcohol or exercise, very good reminders. It’s not, I don’t feel pressured 
by it at all” (SU44) 
 
The care planning function was mentioned least frequently as a useful feature, but some service users found these features helpful: 
 
“I have seen the other aspects of having goals and targets and the reminder to take the medicine etc. They’re less valuable to me in some ways because 
I’ve become reasonably regimented” (SU20) 
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“You can monitor everything: you can monitor your exercise; your medication; you can put appointments on there it reminds you; it emails you 
appointment reminders” (SU29) 
 
Clinic staff or wider informants did not frequently remark on app features. Some have stressed the self-monitoring aspect, where the use of i-spero 
also enabled patients to visualise this progress as evidenced by qualitative data: 
 
“I’d say for a lot of people they like it. I think the really nice thing is that they can see whether they’re improving or not themselves” (FG01T1) 
 
“You just need to look at the scores and you can see people are improving… I think that’s actually boosting the confidence of the staff because they can all 
see that, and it makes them feel proud that they are helping people” (FG02T1)   
 
“The great thing is, you know, we can see from the results that it’s working and I think that’s really the main thing is getting the data to validate that this 
clinic is working, you know, and the software is evidencing that…with the graphing and the scores and the data…to qualify the drugs and treatments that 
are being used, to qualify that there has been a proven improvement”  (WS10) 
 
Others have spoken about the importance of suicide alerts which allow GPs to work more proactively – they can speak to the patient immediately, 
refer to secondary care if necessary. 
